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The	work	 in	 this	 thesis	 aimed	 to	 further	 develop	 these	 Ru(II)(bpy)3	 protein	 surface	
mimetics;	gaining	information	as	to	how	they	interact	with	proteins,	looking	at	new	ways	
of	 achieving	 high	 affinity	 protein	 surface	 recognition	 and	 the	 development	 of	 new	
applications	 for	 these	 molecules.	 In	 Chapter	 2	 an	 indepth	 study	 of	 the	 binding	 of	 two	
Ru(II)(bpy)3	 complexes	 to	 a	 model	 protein,	 cytochrome	 c,	 is	 presented,	 looking	 at	 the	
thermodynamic	and	electrostatic	contributions	to	binding	as	well	as	using	protein	NMR	to	
elucidate	 the	 binding	 site.	 In	 Chapter	 3	 the	 development	 of	 dynamic	 combinatorial	
chemistry	 (DCC)	 scaffolds	 based	 on	 Ru(II)(bpy)3	complexes	 and	 tetraphenyl	 porphyrins	
was	explored	as	a	potential	avenue	for	new	receptor	design,	enabling	the	development	of	
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This	 chapter	 is	 adapted	 from	 ‘Metal	 Complexes	 as	 Protein	 Surface	 Mimetics’,	 S.	 H.	
Hewitt	and	A.	J.	Wilson,	Chem.	Commun.,	2016,	52,	9745-9756	
1.1 Protein-protein	interactions	
Protein-protein	 interactions	 (PPIs)	 are	 ubiquitous	 within	 biology,	 being	 used	 for	 a	
plethora	 of	 different	 processes,	 including	 signal	 transduction,	 antibody	 responses,	 the	
formation	of	complex	structures,	apoptosis	and	the	control	of	the	cell	cycle.1	As	a	result	of	
their	 abundant	 nature,	 the	 modulation	 (inhibition	 and	 stabilisation)	 of	 PPIs	 is	 of	 great	
interest	both	therapeutically	and	for	the	study	of	biological	processes.		
Many	 studies	 have	 been	 performed	 in	 order	 to	 establish	 the	 topology	 and	 chemical	
nature	 of	 the	 protein-protein	 interface,	 but	 these	 have	 led	 to	many	 discrepancies,	 over	
generic	 conclusions	 such	 as	 the	 hydrophobicity	 and	 charge	 content	 of	 the	 interface.2	







The	 nature	 of	 protein	 interfaces	 makes	 targeting	 PPIs	 notoriously	 difficult	 (Figure	
1.1);	indeed	they	have	been	described	as	‘undruggable’,	or	‘high-hanging	fruit’.3	In	order	to	
	 2	
target	 a	 PPI,	 a	 small	 molecule	 that	 binds	 to	 a	 protein	 surface	 is	 required,	 yet	 protein	
surfaces	 are	 often	 large	 (~1500	 –	 3000	 Å2)	 and	 flat,	 lacking	 the	 clefts	 and	 pockets	
associated	with	more	conventional	protein	targets,	 like	enzyme	active	sites	or	G	protein-
coupled	 receptors,	 making	 it	 difficult	 to	 discover	 small	 molecules	 capable	 of	 protein	
surface	recognition.3		
1.1.2 Conventional	methods	for	development	of	protein	surface	ligands	
Various	 different	 approaches	 have	 been	 used	 to	 target	 PPIs.	 Some	 successes	 having	
been	 found	with	peptides	and	peptidomimetics,4	along	with	 fragment	based	approaches,	







The	 screening	 of	 large	 libraries	 of	 drug-like	 molecules,	 followed	 by	 further	
optimization	 has	 yielded	 the	Nutlins	 as	 inhibitors	 of	 the	 p53/hDM2	 interaction	 (Figure	
1.2),7	 the	 most	 potent	 of	 which	 (Nutlin	 3	 (1),	 IC50	0.09	 μM)	 has	 been	 shown	 to	 inhibit	
tumourigenesis	 in	 human	 xenograft	 cells	 in	 vivo.8	 However	 these	 high	 throughput	
approaches	 have	 yielded	 few	 results,	 potentially	 as	 the	 libraries	 being	 screened	 are	



















turns,11	 α-helices12	 and	 β-sheets.13	 These	 allow	 the	mimicry	 of	 the	 secondary	 structural	




An	 example	 of	 an	 α-helical	 secondary	 structure	 mimic	 is	 the	 use	 of	 constrained	
peptides	(Figure	1.4).	In	this	approach	a	sequence	of	α-amino	acids	is	preorganised	into	a	
helical	 conformation	 by,	 for	 example,	 the	 addition	 of	 a	 hydrocarbon	 constraint.14	
Theoretically	 this	 reduces	 the	 entropy	 loss	 on	 binding	 from	 that	 of	 the	 unconstrained	
peptide,	 potentially	 increasing	 the	 binding	 affinity,15	 as	 there	 is	 now	 no	 barrier	 to	 the	
formation	 of	 the	 bound	 helical	 conformation.	 The	 introduction	 of	 the	 constraint	 also	











binding	 groups	 over	 a	 large	 area	 of	 protein	 surface	 (Figure	 1.5),17–19	 to	 achieve	 high	
affinity	protein	binding.	This	allows	 for	 the	recognition	of	 large	areas	of	protein	surface,	
with	 fewer	 discernable	 features	 than	 can	 be	 recognised,	 for	 example	 by	 a	 secondary	
structure	mimetic.	 The	binding	utilizes	multivalency,	 the	 interaction	 of	multiple	 binding	
groups	 located	 around	 a	 central	 scaffold	 on	 a	 host	molecule	 (surface	mimetic),	 towards	
multiple	 recognition	 sites	 on	 a	 receptor	 molecule	 (protein)	 in	 order	 to	 achieve	 high	
affinity	binding.19	Multivalency	is	widely	used	in	nature,20	where	it	allows	for	an	increased	














with	 recognition	 elements	 for	 protein	 surface	 recognition.21	 The	 Hamilton	 group	 have	
synthesised	 calix[4]arene	 derivatives	which	 bind	 to	 cytochrome	 (cyt)	 c,	 α-chymotrypsin	
(α-ChT)	 and	platelet-derived	growth	 factor	 (PDGF),	 acting	 as	 antibody	mimics.22–25	GFB-
111	(3)	(Figure	1.6a),	a	PDGF	binder	with	IC50	250	nM,	was	shown	to	be	functional	in	vivo	
(mouse).25	 Crowley	 and	 coworkers,	 more	 recently,	 solved	 a	 crystal	 structure	 of	 a	 p-





group	 used	 calixarenes	 along	 with	 readily-available	 dyes	 to	 form	 dye-displacement	
sensors	for	anti-body	free	reading	of	histones	through	lysine	side	chain	recognition.28		
1.2.1.2 Resorcinarenes	
Uchiyama	 and	 coworkers	 developed	 the	 use	 of	 resorcinarene	 scaffolds	 for	 histone	
surface	recognition	(Figure	1.7).29–32	Histones	are	basic	proteins,	containing	many	lysine	
residues,	so	the	development	of	the	resorcinarene	compounds	with	many	carboxylic	acids	







They	 were	 also	 shown	 to	 be	 selective	 for	 histones	 over	 lysozyme	 and	 ovalbumin,	 with	
binding	 increasing	 with	 increasing	 numbers	 of	 carboxylates.30	 They	 later,	 transformed	
their	 tetrameric	 (28	 carboxylate)	 ligand	 (4)	 into	 one	 that	 could	 be	 used	 in	 fluorescence	
intensity	assays,	by	changing	one	of	the	resorcinarene	units	to	a	fluorescent	dansyl	group.	
The	 fluorescence	of	 this	dansyl	group	showed	a	5-fold	 increase	 in	 fluorescence	 intensity	
on	 saturation	with	 histone,	 and	 indicated	 the	 dansyl	moiety	 as	 being	 located	 on	 a	 non-
polar	region	of	the	histone	surface.31	The	binding	affinity	was	found	to	be	in	the	region	of	
106	M-1	with	1:1	binding	demonstrated	by	this	fluorescence	intensity	assay,	and	SPR.	The	
Ka	 was	 found	 to	 be	 higher	 at	 lower	 ionic	 strengths,	 thus	 implicating	 electrostatics	 as	 a	
major	driving	force	for	binding.	The	binding	to	~70	%	acetylated	histone	was	also	shown	
to	 be	 negligible.31	 Further	modifications	 to	 the	 tetrameric	 ligand	 (4)	 yielded	 a	 rotaxane	





























































































to	 a	 variety	 of	 different	 proteins,	 including	Kv	 potassium	 channels,37–41	 VEGF,42	 cyt	 c43,44	
and	lectins.45–47	
Trauner	and	coworkers	rationally	designed	a	tetraphenylporphyrin-based	scaffold	(5)	
to	 target	 the	 Kv	 potassium	 channel	with	 nanomolar	 affinity	 (Figure	 1.8a),	 reducing	 the	
































































The	 Yayon	 group	 have	 studied	 other	 porphyrins	 (6)	 that	 bind	 to	 fibroblast	 growth	
factor	 (FGF)	 and	 vascular	 endothelial	 growth	 factor	 (VEGF)	 (Figure	 1.8b),42	 with	 low	
micromolar	affinity	 in	vitro,	 in	cellulo,	 and	 in	vivo.	They	also	 showed	 they	were	 selective	
inhibitors	 of	 the	 VEGF/VEGF	 receptor	 PPI	 over	 the	 EGF/EGF	 receptor	 PPI.	 Further	





The	 binding	 of	 porphyrins	 to	 lectins	 has	 been	 extensively	 studied	 with	 crystal	
structures	 having	 been	 solved	 for	 tetrasulfonatophenyl	 porphyrin	 binding	 to	 Jacalin	










Dendrimers	 are	 supramolecular	 scaffolds	 of	 high	 valency,	 with	 a	 central	 core	 that	
projects	 a	 branching	 network	 of	 repeating	 units	 culminating	 in	 terminal	 functionality	
which	can	be	used	for	binding	to	proteins	(Figure	1.10).53	Twyman	and	coworkers	have	
designed	 poly	 anionic	 poly(amidoamine)	 (PAMAM)	 dendrimers	 (Figure	 1.11,	8)	 which	
bind	to	cyt	c	and	α-ChT.54	The	best	 ligands	for	both	proteins,	are	those	whose	maximum	




Giri	 group.56	 They	 studied	 binding	 constants,	 NMR	 (1H,	 STD	 and	 DOSY)	 and	 molecular	
dynamic	 (MD)	 simulations	 of	 19	 PAMAM	 dendrimers	 in	 order	 to	 gain	 insight	 into	 the	
interactions,	looking	at	differences	in	core,	dendrimer	generation	and	terminal	group.	This	
allowed	 for	 an	 analysis	 of	 the	 effect	 of	 hydrogen	 bonding,	 hydrophobicity,	 and	
electrostatic	interactions	on	the	binding	to	HSA.	The	NMR	and	MD	simulations	show	that	






and	 lysozyme	 (Figure	 1.12).57	 The	 anthracene	 analogues	 (9)	 have	 a	 hydrophobic	 core	






























































surfaces.	 0.66	 and	 0.52	 μM	 binding	 affinities	 (5	 mM	 sodium	 phosphate,	 pH	 7.4	 buffer)	
were	observed	for	cyt	c	and	 lysozyme	respectively	using	a	 fluorescence	quenching	assay	




Bivalent	 cyclodextrins	 have	 been	 synthesised,	 by	 Breslow	 and	 coworkers,	 to	 inhibit	
aggregation	 of	 citrate	 synthase	 and	 L-lactate	 dehydrogenase,	 by	 binding	 to	 (and	 thus	





driven,	 electrostatic	 binding,	 with	 NMR	 suggesting	 binding	 at	 the	 haem	 exposed	 edge.	
Further	confirmation	and	proposals	for	other	binding	sites	were	obtained	by	observation	
of	partial	inhibition	of	ascorbate	reduction,	and	a	decrease	in	reduction	rate	of	cyt	c	in	the	





to	 offer	 a	 wider	 variety	 of	 coordination	 numbers	 and	 geometries,	 thus	 expanding	 the	
number	of	globular	shapes	available,	allowing	the	potential	for	them	to	fit	into	pockets	and	
onto	surfaces	not	accessible	to	small	organic	molecules.60	Metal	complexes	can	also	exist	
as	many	more	 stereoisomers	 than	 organic	molecules,	 for	 example	 an	 sp3	 carbon	with	 4	
different	 substituents	has	only	 two	possible	 stereoisomers	whereas	an	octahedral	metal	
































wide	 range	 of	 metal	 complexes	 using	 similar	 reactions,61	 allowing	 the	 screening	 of	 a	
variety	of	compounds	more	easily.	The	metal	centre	itself	can	be	used	solely	as	a	scaffold,	
for	 forming	 coordinative	 bonds	 with	 biological	 macromolecules,	 and	 for	 its	 reactive	




The	 use	 of	 metal	 scaffolds	 as	 molecular	 sensors	 also	 offers	 advantages	 over	
conventional	small	molecules,	as	 it	 is	possible	to	choose	a	metal	scaffold	which	can	itself	
be	 visualised	 using	 its	 intrinsic	 luminescence,	 rather	 than	 requiring	 functionalization	 of	
the	 organic	 framework,	 which	 may	 have	 an	 effect	 on	 binding,	 and	 other	 molecular	
properties,	 such	as	 solubility.	For	example	 ruthenium(II)	 and	 iridium(III)	 complexes	are	
phosphorescent,	 allowing	 for	 their	 direct	 visualisation	 in	 both	 biological	 assays	 and	 for	
cellular	imaging.63	
1.2.2.2 Metal	coordination	to	protein	surfaces	
Metal-ligand	 interactions	 in	 water	 are	 stronger	 than	 the	 conventionally	 important	
protein	 recognition	 interactions	 such	 as	 hydrogen-bonding,	 electrostatics	 and	 van	 der	









recognition	 of	 proteins,	 as	 fewer	 interactions	 will	 be	 needed	 to	 achieve	 high	 affinity,	






Mallik	 and	 coworkers	 used	 the	 knowledge	 that	 many	 transition	 metals	 bind	 to	 the	
imidazole	side	chains	of	histidines	on	proteins,	a	widely	used	concept	in	the	purification	of	
proteins	 by	 immobilized	 metal	 affinity	 chromatography.65–67	 They	 used	 molecules	 with	
copper(II)-iminodiacetate	 (IDA)	 arms	 to	 recognise	 patterns	 of	 surface-exposed	 histidine	
residues	 (Figure	 1.14),	 	 resulting	 in	 recognition	 of	 bovine	 erythrocyte	 carbonic	
anhydrase,68,69	 after	 seeing	 that	 they	 could	 be	 used	 to	 bind	 to	 histidines	 on	 peptides	 in	
solution.70,71	A	three	Cu(II)	system	(10)	was	used	to	bind	three	histidine	side	chains	on	the	
N-terminus	 of	 the	 carbonic	 anhydrase,	 with	 the	 ligand	 alone	 showing	 no	 binding,	
illustrating	 the	 importance	 of	 the	 metal	 centre	 for	 recognition.	 The	 highest	 affinity	
compound	(10,	3	μM	Kd	by	ITC)	was	also	found	to	be	selective	for	carbonic	anhydrase	over	
chicken	 egg	 albumin,	 a	 protein	 with	 the	 same	 number	 of	 surface	 exposed	 histidine	
residues	(six)	but	in	different	spatial	orientations.		
Along	 similar	 lines,	 Hamachi	 and	 coworkers	 used	 bis(Zn(II)-dipocolylamine	 (Dpa)))	
derivatives	to	bind	histidine	residues	on	the	surface	of	α-helical	peptides,	stabilising	their	
α-helical	 conformations.72,73	 This	 lead	 to	 the	use	 of	 the	bis(Zn(II)-Dpa)	 complexes	 in	 the	
binding	of		both	mono-	and	multi-	phosphorylated	peptides	via	bidentate	binding	between	
the	 Zn(II)	 and	 the	 phosphate	 groups,	 resulting	 in	 stabilisation	 of	 the	 peptides	 (Figure	
1.15).74,75	The	targeting	of	phosphate	groups	on	protein	surfaces	 is	of	particular	 interest	
	 13	
as	 protein	 phosphorylation	 is	 used	 as	 a	 ubiquitous	 signaling	mechanism	within	 cells	 so	





	The	bis(Zn(II)-Dpa)	 species	 have	 been	 used	 to	 generate	 chemosensors	 tailoring	 the	
bridging	 group	 between	 the	 two	 Zn(II)	 centres	 to	 cause	 a	 change	 in	 fluorescence	 on	
binding,	 in	 Hamachi’s	 case	 this	 involved	 using	 anthracene	 or	 bipyridine	 moieties,	 thus	
allowing	 for	 fluorescence	 binding	 assays	 to	 be	 developed.74–77	 Using	 di-phosphorylated	
model	 α-helical	 peptides	 it	 was	 shown,	 by	 CD,	 that	 appropriately	 spaced	 Zn(II)	 centres	
increased	 the	 α-helical	 content	 of	 the	 peptide.	 They	 showed	 10-fold	 selectivity	 for	 di-
phosphorylated	 over	 mono-phosphorylated	 peptides,	 but	 little	 selectivity	 between	
different	di-phosphorylated	peptides,	due	to	the	high	flexibility	in	the	linker	between	the	




relationships	 between	 the	 phospho-amino	 acids	 residues.80	 Zn(II)	 complexes	 based	 on	




Zn(II)-(Dpa)	 complexes	 to	 bind	 to	 phospho-tyrosine	 STAT3,	 inhibiting	 STAT3/STAT3	
dimerisation.82,83	 ITC	 and	 fluorescence	 polarisation	 data	 showed	 the	 Cu(II)	 complexes	
binding	 to	 a	 phospho-peptide	 (with	 micromolar	 Kd),	 inhibiting	 the	 phospho-peptide-
protein	 complex,	 with	 micromolar	 Ki.82	 The	 Cu(II)	 complexes	 were	 further	 shown	 to	
inhibit	STAT3/STAT3:DNA	binding,	using	an	electrophoretic	mobility	shift	assay,	with	8.2	
μM	affinity	 for	 the	 highest	 affinity	 ligand.	 	 They	 also	 exhibited	 low	micromolar	 IC50	in	 3	























both	 metallo	 and	 non-metallo	 anionic	 porphyrins	 and	 cyt	 c.84–91	 With	 two	 types	 of	
porphyrins	being	compared:	uroporphyrins	and	4-carboxyporphyrins	by	Jameson	et	al.89	
in	1997.	4-Carboxy	porphyrins	were	shown	to	have	higher	fluorescence	quenching	rates,	
probably	 due	 to	 the	 difference	 in	 orientation	 for	 the	 two	 porphyrins,	 which	 can	 be	
visualised	 by	 the	 induced	 CD	 of	 the	 porphyrins	 on	 binding	 to	 cyt	 c.	 Interestingly	 these	
original	porphyrins	do	not	affect	the	CD	of	cyt	c	at	room	temperature,	indicating	that	there	
is	no	change	in	protein	tertiary	structure	on	binding.	The	Rodgers	group	also	used	cationic	
metalloporphyrins	 as	 extrinsic	 probes	 to	 study	 peptide	 aggregation	 by	 analysing	
photoinduced	electron	transfer	(PET)	from	tyrosine	or	tryptophan	residues	in	the	protein	
to	the	metalloporphyrin.92,93	
Following	 Fisher’s	 initial	 observation	 that	 tetra-carboxy	 phenyl	 porphyrin	 bound	 to	





receptors	 for	 cyt	 c	 	 and	 showed	 that	 increasing	 the	 number	 of	 carboxylates	 on	 the	
periphery	 led	 to	 significant	 increases	 in	 binding	 affinity.44	 They	 also	 showed	 that	 there	
were	 changes	 in	 affinity	 by	 altering	 the	 relative	 proportions	 of	 acidic	 and	 aromatic	
functionalities.43,44	 The	 compounds	were	 found	 to	 be	 selective	 for	 cyt	 c	 over	 the	 related	
proteins,	 cyt	 c551	 and	 ferredoxin.44	 Crowley	 and	 coworkers	 later	 analysed	 sulfonato-
porphyrins	 binding	 to	 cyt	 c	 by	 1H-15N	 HSQC	 NMR,	 with	 the	 results	 corroborated	 by	
molecular	 docking.26	 They	 showed	 that	 a	 dynamic	 ensemble	 of	 energetically	 similar	







Interestingly	 the	 compounds	 were	 found	 to	 denature	 cyt	 c,	 shown	 by	 a	 lowered	
melting	temperature	(Tm),96	by	up	to	50	°C.44	The	anionic	tetra-phenyl	porphyrins	(11	and	
12,	 M	 =	 2H,	 Figure	 1.16a)	 had	 a	 more	 profound	 effect	 compared	 to	 similarly	 charged	













60	 nM	 affinity	 for	 cyt	 c	 and	 bind	 in	 a	 2:1	 porphyrin:protein	 ratio,	 with	 the	 porphyrins	







































rates.	 There	 are	 significant	 differences	 between	 the	 free	 base,	 where	 there	 is	 some	
lowering	of	the	Tm,	and	the	Cu(II)	porphyrins,	which	have	much	larger	effects	arising	from	
the	 dimeric	 nature	 of	 the	 Cu(II)	 porphyrins	 compared	 to	 the	 monomeric	 free	 base	
porphyrins	 (M	=	2H).	 In	order	 to	bind	 to	 the	native	 cyt	c	 structure	 the	Cu(II)	porphyrin	
dimers	may	have	 to	dissociate,	whereas	 to	bind	 to	 the	denatured	 cyt	c	 they	do	not,	 this	




Geobacter	 sulfureducens,	 hen	 egg	 lysozyme	 and	 horse	 heart	 cyt	 c	 at	 high	 (millimolar)	





Zn(II)	 porphyrin-based	 dendrimers	 have	 also	 been	 developed,	 with	 the	 fluorescent	
metalloporphyrin-core	 being	 utilised	 for	 detection	 (Figure	 1.17).104	 These	 large	
multivalent	nanoscale	structures	have	been	used	to	bind	to	cyt	c,	with	the	cyt	c/dendrimer	
complex	 being	 more	 stable	 than	 the	 native	 cyt	 c/cyt	 b5	 PPI,	 evidenced	 by	 20	 %	




























































complex.	 One	 of	 these	 original	 Zn(II)-porphyrin	 dendrimers	 (13),	 and	 subsequent	
generations,	were	shown	to	improve	cell	viability	when	cells	are	subjected	to	an	apoptotic	








The	 use	 of	 metals	 as	 scaffolds	 for	 protein	 binding	 molecules	 has	 been	 pursued	 by	
many	 groups,	 with	 the	 Meggers	 group	 being	 a	 front-runner.	 They	 have	 mainly	 used	
ruthenium(II)	 complexes	 (Figure	 1.18),	 but	 more	 recently	 have	 branched	 out	 to	 using	
rhodium(III),106,107	iridium(III),108,109	osmium(II)110	and	platinum(II)111	for	the	inhibition	of	
many	 different	 protein	 	 kinases	 including	 Pim1,112,113	 glycogen	 synthetases	 kinase	 3β	
(GSK3β),114	 MSK1,112	 BRAF	 kinase,115	 and	 PAK1.116	 X-ray	 crystal	 structures	 have	 been	
solved	 for	 many	 of	 these	 compounds	 bound	 to	 their	 target	 kinases	 (Figure	 1.18b),	
showing	the	metals	acting	in	purely	structural	capacities.113,117	The	majority	of	these	have	
been	adenosine	triphosphate	(ATP)	mimics,	being	based	on	staurosporine	(14),	a	widely	
studied	organic	ATP	mimic,	but	non-ATP	mimics	have	been	 studied	more	 recently,118	 as	
have	 inhibitors	of	other	nucleotide	binding	proteins	 including	 the	human	repair	enzyme	
7,8-dihydro-8-oxoguanosine	triphosphatase,119	and	the	lipid	kinase	PI3K.120	
	 18	







The	Leung	group	have	worked	on	multiple	 Ir(III)	and	Rh(III)	 compounds,	 capable	of	
binding	to	protein	surfaces.	They	first	developed	cyclometalated	Ir(III)	complexes	capable	
of	binding	 to	 tumour	necrosis	 factor-α	(TNF-α).121	The	 Ir(III)	complex	developed	utilises	
the	 aromatic	 bidentate	 ligands	 2-phenylpyridinato	 (ppy)	 and	 2,2’-biquinoline	 (biq)	
(Figure	 1.19a),	 in	 order	 to	 target	 a	 hydrophobic	 binding	 site	 on	 the	 TNF-α	 dimer,	
preventing	active	 trimer	 formation.	Both	enantiomers	of	 the	 Ir(III)	 complex	were	 found,	
by	ELISA,	to	have	an	IC50	in	the	region	of	20	μM,	comparable	to	that	of	SPD304,122	one	of	
the	 strongest	 inhibitors	 of	 TNF-α.	 Structure-activity	 relationships	 have	 since	 been	
performed,	using	22	Ir(III)	complexes	with	ligands	of	different	shapes	and	sizes	in	order	to	
generate	 low	 micromolar	 inhibitors	 (Figure	 1.19b)	 (seen	 in	 an	 in	 cellulo	 inhibition	 of	
TNF-α	induced	NF-κB	luciferase	assay	in	HEP	G2	cells).123	They	also	looked	at	the	effect	of	
stereochemistry,	 comparing	 the	 Δ	 and	 Λ	 isomers,	 showing	 that	 the	 Λ	 isomers	 had	
increased	 cellular	 activity	 (3.4	 μM	 versus	 9.9	 μM	 IC50	 in	 the	 cellular	 assay)	 and	 binding	
affinity	(30	versus	57	μM	IC50	in	an	in	vitro	assay).123	
They	 have	 synthesised	 Ir(III)	 and	 Rh(III)	 compounds	 capable	 of	 binding	 to,	 and	

































potent	 Rh(III)	 compound	 (20)	 was	 found	 to	 have	 anti-tumour	 activity	 in	 a	 mouse	
xenograft	tumour	model	and	was	found	to	bind	to	the	SH2	domain	of	STAT3	with	an	IC50	
of	 4.8	 μM.	 STAT3	 pull-down	 assays	 showed	 an	 inhibition	 of	 STAT3	 dimerisation	 and	
Western	 blotting	 showed	 an	 inhibition	 of	 STAT3	 phosphorylation.	 The	 group	 have	 also	
screened	 a	 series	 of	 iridium(III)	 complexes	 as	 inhibitors	 of	 the	 p53/hDM2	 interaction	
(Figure	 1.19d).125	 One	 compound	 (21)	 was	 shown	 to	 be	 a	 16	 µM	 inhibitor	 in	 a	





1.20a)	 of	 the	 interaction	 between	 bromodomain-containing	 protein	 4	 (BRD4)	 and	 an	
acetylated	 histone	 peptide.126	 They	 initially	 screened	 27	 compounds	 and	 found	 a	
compound	 capable	 of	modulating	 the	 interaction	 between	 BRD4	 and	 chromatin	 in	 vitro	
and	 in	 vivo.	 The	 compound	 was	 found	 to	 bind	 to	 histidine	 residues,	 with	 the	 loss	 of	
acetonitrile	 ligands,	 and	 was	 found	 to	 be	 selective	 over	 the	 other	 histidine	 containing	
proteins	 STAT3	 and	 caspase-6.	 They	 have	 also	 developed	 Ir(III)	 and	 Rh(III)	 complexes	
(Figure	 1.20b)	 	 that	 inhibit	 the	 aggregation	 of	 Aβ1-40,127	 a	 peptide	 implicated	 in	
neurodegenesis	 in	Alzheimer’s	disease.	The	compounds	bind	 to	histidine	residues	 in	 the	
peptide,	replacing	the	water	ligands	with	these	histidines,	allowing	further	interactions	of	





phenanthroline	 (phen)	 ruthenium(II)	 complexes	 show	 bacteriostatic	 and	 bacteriocidal	
activities	and	also	 inhibit	 tumour	growth,	 thus	showing	 the	potential	biological	utility	of	





















has	been	used	by	 the	Sasaki	and	de	Mendoza	groups	 in	order	 to	generate	 lectin	binding	
complexes.131,132	 Sasaki	 and	 coworkers	 generated	 an	 Fe(II)(bpy)3	 complex	 with	 mono-
GalNAc	substituted	bpy	ligands,	which	altered	its	stereochemical	configuration	in	solution	
resulting	 in	 the	 enrichment	of	 higher	 affinity	 compounds	 for	 various	different	 lectins.131	
De	 Mendoza	 and	 co-workers	 used	 bipyridines	 functionalised	 with	 3	 different	 sugars,	
complexed	 them	 to	 Fe(II)	 then	 incubated	 the	 Fe(II)(bpy)3	complexes	with	 the	mannose-
binding	 lectin,	 Con	 A,	 this,	 as	 predicted,	 resulted	 in	 the	 enrichment	 of	 the	 mannose	
functionalised	complex	(detected	by	LCMS).132	
While	the	labile	nature	of	the	Fe(II)(bpy)3	complexes	can	be	useful	for	the	generation	and	
selection	 of	 high	 affinity	 protein	 binders,	 the	 inert	 nature	 of	 	 Ru(II)(bpy)3	 is	 of	 great	
interest,	 as	 	 decomplexation	 will	 not	 occur	 in	 biological	 media	 in	 dilute	 solution.133	 130	
Kaboyashi	 and	 coworkers,133,134	 generated	 a	 series	 of	 	 glyco-functionalised	 Fe(bpy)3	and	
Ru(II)(bpy)3	compounds,	and	showed	that	the	ruthenium(II)	glycoclusters	had	high	lectin	
affinity	 and	 increased	 luminescence	 on	 lectin	 binding.	 The	 Seeberger	 group	 have	 since	
developed	sugar	functionalised	Ru(II)(bpy)3		complexes	(24)	that	bind	to	the	concavalin	A	










lectin	binders	 for	 further	 study,	by	assessing	 the	 increase	 in	 luminescence	output	of	 the	
Ru(II)glycodendrimers	with	various	different	 lectins.136	The	Ru(II)(bpy)3	complexes	with	
surface	 bound	 lectins	 have	 also	 been	 used	 as	 luminescent	 sensors	 for	 measuring	
monosaccharide	 and	 oligosaccharide	 concentrations,	 by	 using	 the	 displacement	 of	 the	
Ru(II)glycodendrimers	 from	 the	 lectin	 surface	 by	 the	 sugars.137	 They	 then	 further	
functionalised	 their	 Ru(II)(bpy)3	 complex	 scaffold,	 by	 addition	 of	 adamantine	 units,	 and	
adding	mannose	functionalised	β-cyclodextrin	to	encapsulate	the	adamantane	units,	thus	
making	a	highly	mannose	 functionalised	 subunit	which	binds	 to	high	density	ConA	with	
0.14	 μM	 Kd,	 as	 determined	 by	 SPR.138	 The	 Okada	 group	 have	 also	 looked	 at	 sugar	
















































































































Ru(II)(bpy)3	 complexes	 bind	 to	 peanut	 agglutinin	 with	 6.1	 μM	 Kd	 and	 glucose	
functionalised	Ru(II)(bpy)3	complexes	bind	to	ConA	with	18	μM	Kd,	by	both	fluorescence	
emission	and	polarisation	assays.139		
Electron	 transfer	 experiments	between	 cyt	c	 and	Ru(II)(bpy)3	 complexes	 (as	well	 as	
Ru(II)(phen)3,	Os(II)(bpy)3	and	Os(II)(phen)3	complexes)	were	initially	reported	by	Cho	in	
the	 1980s.140	 Subsequently	Hamachi	 and	 coworkers	 reported	 carboxylate	 functionalised	
Ru(II)(bpy)3	derivatives	(25,	Figure	1.23)	that	could	bind	to,	and	photoreduce	cyt	c	(pI	=	
10.0)	 selectively	 over	 other	 proteins	 (myoglobin,	 horseradish	 peroxidase	 and	 cyt	 b562)	
with	 lower	 pIs	 (7.0,	 8.0	 and	 5.0	 respectively).141	 The	 Ru(II)(bpy)3	 complexes	 25	 were	
found	to	bind	to	cyt	c,	by	an	ultrafiltration	binding	assay.	The	compound	with	the	highest	
number	of	carboxylic	acids	(18)	was	shown	to	bind	an	order	of	magnitude	better	than	an	
unfunctionalised	 Ru(II)(bpy)3	 complex.	 The	 Ru(II)(bpy)3	 complexes	 were	 capable	 of	
photoreducing	 cyt	 c	 with	 the	most	 effective	 being	 an	 asymmetric	 Ru(II)(bpy)3	 complex	





Following	 on	 from	 Hamachi’s	 initial	 observations	 both	 the	 Ohkanda	 and	 Wilson	
groups	further	established	selective	binding	of	Ru(II)(bpy)3	complexes	to	cyt	c	and	α-ChT	
(Figure	 1.24).	 The	Wilson	 group	 developed	 both	mono-	 (5’)	 (27a)	 and	 di-	 (4,4’)	 (26a)	
substituted	bpy	moieties	which,	when	complexed	to	ruthenium(II),	show	1.6	nM	binding	
affinity	 (26a,	 5	 mM	 sodium	 phosphate,	 pH	 7.4)	 for	 cyt	 c	by	 a	 luminescence	 quenching	
assay.142,143	 As	with	 Hamilton’s	 porphyrins,43	 negatively	 charged	 substituents	 (based	 on	
aspartic	acid	moieties)	show	good	binding	in	luminescence	quenching	assays.142	Negative	
cooperativity	was	observed,	with	increasing	numbers	of	carboxylates,	the	binding	affinity	

























the	Δ	 isomers,	5	mM	sodium	phosphate,	pH	7.4)	than	the	 fac	 isomers	for	cyt	c,	but	the	Δ	
and	Λ	isomers	showed	little	difference	in	their	binding	affinities	(25	vs	29	nM	for	the	mer	
isomers).143	Further	analysis	by	a	 functional	ascorbate	assay	showed	that	both	the	(4,4’)	
disubstituted	 and	 5’	 monosubstituted	 bipyridines	 slow	 the	 rate	 of	 reduction	 of	 cyt	 c,	
probably	 as	 a	 result	 of	 blocking	 the	 approach	 of	 the	 reducing	 agent	 to	 the	 haem	group,	
which	 is	 surrounded	 by	 basic	 amino	 acid	 residues.142	 The	 absence	 of	 binding	 to	 60	 %	
acetylated	 cyt	 c	 confirms	 that	 the	 charge	 complementarity	 is	 key	 to	 binding.142,143	 The	
binding	of	the	Ru(II)(bpy)3	complex	26a,	similarly	to	Hamilton’s	porphyrins,98	lowers	the	
melting	 temperature	 of	 cyt	 c	 by	 25	 °C	 and	 shows	 an	 increased	 rate	 of	 proteolytic	
degradation	 in	 both	 stoichiometric	 and	 substoichiometric	 quantities	 of	 the	 Ru(II)(bpy)3	
complex.144	At	higher	 temperatures	 there	 is	 a	 change	 in	binding	 stoichiometry	observed	
with	 a	 change	 from	 1:1	 binding	 to	 	 2:1	 (protein:Ru(II)(bpy)3	 complex)	 binding	 being	
observed	on	changing	from	25	to	70	°C.		In	cellulo	work	has	also	been	performed	with	the	






Ohkanda	 and	 co-workers	 have	 shown	 that	 similar	 dendritic	 Ru(II)(bpy)3	 complexes	
(26b,	Figure	 1.24)	 bind	 to	 α-ChT	 in	 a	mixed	 1:1	 and	1:2	 (Ru(II)(bpy)3	 complex:α-ChT)	
stoichiometry	with	130	and	430	nM	Kds	(5	mM	phosphate,	pH	7.4)	for	the	first	and	second	
equilibrium	 step	 respectively,	 inhibiting	 the	 enzyme	 by	 non-competitive	 inhibition.146	
They	 later	 synthesised	 heteroleptic	 Ru(II)(bpy)3	 complexes,	 containing	 multiple	






























































• Furthering	 the	 understanding	 of	 the	 binding	 of	 previously	 designed	
Ru(II)(bpy)3	to	the	surface	of	cyt	c,	by	elucidating	more	information	about	the	
binding	mode	and	the	interactions	involved	in	binding,	as	well	as	the	location	
of	 the	 binding	 sites.	 	 This	 allowed	 a	 more	 complete	 understanding	 of	 how	
Ru(II)(bpy)3	 complexes	bind	 to	proteins,	 to	 allow	 for	 further	 rational	design	
for	binding	to	other,	more	therapeutically	interesting,	protein	surfaces.	
• The	development	of	 a	 suitable	 scaffold	 for	dynamic	 combinatorial	 chemistry	
in	 order	 to	 generate	 higher	 affinity,	 and	 less	 symmetrical	 Ru(II)(bpy)3	
complex,	and	porphyrin	binders	for	different	proteins.		
• The	 design	 of	 a	 protein	 sensing	 array	 using	 Ru(II)(bpy)3	 complexes	 to	
discriminate	between	 a	 variety	 of	 different	protein	 surfaces,	 to	 give	 another	
potential	protein	surface	binding	application	of	these	Ru(II)(bpy)3	complexes.	
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2 Biophysical	 and	 Structural	 Studies	 on	 Cytochrome	 c	







gram	quantities;	 this	makes	 it	 an	 ideal	 protein	 for	 the	 study	of	 how	different	molecular	
scaffolds	 can	be	used	 to	bind	 to	protein	 surfaces.	 In	 this	work,	 cyt	c	 has	been	used	as	 a	
model	 protein	 for	 understanding	 how	 Ru(II)(bpy)3	 complexes	 bind	 to	 the	 surface	 of	
proteins.	The	cyt	c	binding	of	a	range	of	Ru(II)(bpy)3	complexes	has	been	studied,	followed	
by	a	more	 in	depth	study	of	 the	binding	of	 two	of	 these	Ru(II)(bpy)3	 complexes	 to	 cyt	c	
aimed	 at	 understanding	 how	 these	 Ru(II)(bpy)3	 complexes	 interact	 with	 cyt	 c,	 if	 they	
mimic	 the	 cyt	c/cyt	c	 peroxidase	 (CCP)	PPI,	 and	also	 to	elucidate	 the	binding	 site	of	 the	
Ru(II)(bpy)3	complexes	on	cyt	c.	Increased	knowledge	of	how	Ru(II)(bpy)3	complexes	bind	








Cyt	 c	 is	 a	 small,	 basic	 haem	 protein	 ordinarily	 located	 in	 the	 inner	 mitochondrial	









has	been	very	well	 studied,152	 it	was	 the	 first	non-antibody	PPI	 to	have	 its	X-ray	 crystal	
structure	solved	(Figure	 2.1a).153	The	cyt	c/CCP	binding	 interface	 is	 located	close	 to	 the	
haem	 exposed	 edges	 on	 both	 cyt	 c	 and	 CCP,153	 this	 allows	 it	 to	 perform	 its	 function,	
transferring	 electrons	 between	 the	 two	 proteins.	 The	 binding	 is	 based	 on	 a	 central	
hydrophobic	 core	 of	 amino	 acids	 on	 both	 proteins,	 surrounded	 by	 basic	 amino	 acid	
residues	on	cyt	c	and	acidic	amino	acid	residues	on	CCP	(Figure	2.1b).153	This	allows	for	
charge-charge	 complementarity	 between	 the	 two	 protein	 surfaces.	 The	 binding	 is	 very	
ionic	strength	dependent,	indicating	a	large	electrostatic	driving	force	to	binding,	showing	
the	 importance	 of	 this	 charge-charge	 complementarity.154	 The	 binding	 interaction	 is	
entropy-driven,	and	is	even	enthalpically	unfavourable.155			
2.2 Ru(II)(bpy)3	complexes	for	binding	to	cyt	c	
Different	multivalent	 scaffolds	 have	 been	 used	 to	 design	molecules	 to	 bind	 to	 cyt	 c,	












































































Ru(II)(bpy)3	 complexes	26,	29,	31,	 34	 and	 35	 had	 previously	 been	 synthesised	 by	 the	
Wilson	 group	 for	 binding	 to	 cyt	 c.142	 The	 Ru(II)(bpy)3	 complexes	 26,	 29	 and	 31	 were	
functionalised	with	multiple	carboxylic	acid	moieties	 in	order	to	bind	to	the	basic	amino	
acid	 residues	 on	 cyt	 c.	 	 Ru(II)(bpy)3	 complex	 34	 possesses	 crown	 ether	 moieties	 was	
designed	 to	 potentially	 chelate	 the	 lysine	 residues	 on	 cyt	 c,	 however	 no	 binding	 was	
detected,	 and	Ru(II)(bpy)3	 complex	35	was	designed	 as	 a	 negative	 control,	 being	 amine	
functionalised	it	should	not	bind	to	the	basic	cyt	c.	In	addition	to	the	previously	designed	
Ru(II)(bpy)3	 complexes,	 Ru(II)(bpy)3	 complexes	 30	 and	 32	 have	 been	 synthesised	 in	
order	to	further	expand	the	number	of	Ru(II)(bpy)3	complexes	(Ru(II)(bpy)3	complex	32	
was	synthesised	by	Georgina	Pleasance)	 to	see	 if	 the	spatial	 location	of	 the	carboxylates	
affects	 binding	 affinity.	 The	 synthesis	 of	 Ru(II)(bpy)3	 complex	 33	 was	 also	 attempted,	











for	 the	 amide	 bond	 formation	 were	 synthesised	 as	 in	 Scheme	 2.1a,	 by	 amide	 bond	
formation,	 via	 the	 diacid	 chloride,	 on	 5-nitro	 isophthalic	 acid	 36,	 followed	 by	
hydrogenation	of	 the	nitro	group	to	the	aniline	38.	These	hydrogenation	reactions	could	
not	 be	performed	on	 large	 scale,	 as	 there	was	no	 reaction	 or	 incomplete	 reaction	when	
performed	on	more	than	1	g	scale.	
The	 bipyridine	 ligands	 41	 synthesised	 were	 then	 complexed	 to	 ruthenium(II)	 using	
Wilkinson’s	 reagent	 (Ru(II)(DMSO)4Cl2)156	 to	 yield	 the	protected	Ru(II)(bpy)3	 complexes	
42.	 These	 protected	 Ru(II)(bpy)3	 complexes	42	were	 purified	 by	 conventional	 silica	 or	
alumina	 column	 chromatography.	 This	 purification	 was	 changed	 from	 the	 previously	
reported	 ion	 exchange	 Sephadex	 columns,142,143	 as	 Ru(II)(bpy)3	 complexes	 with	 large	
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attempted.	 A	 methyl	 ester	 strategy	 with	 only	 50	 equivalents	 (~2	 per	 acid)	 of	 lithium	





















by	 a,	 previously	 reported,	 luminescence	 quenching	 assay	 (Figure	 2.3).142,143	 The	
Ru(II)(bpy)3	 complexes	 are	 luminescent,	 when	 excited	 by	 light	 at	 467	 nm,	 they	
consequently	emit	 light	 at	~625	nm,	however	when	bound	 to	 cyt	c	 this	 luminescence	 is	
quenched	by	photoinduced	electron	transfer	(PET)	to	the	iron	in	the	haem	group	of	cyt	c.		
	 30	







Previously	 the	 luminescence	 quenching	 assays	were	 performed	 on	 a	 fluorometer,142		
however	 this	 does	 not	 allow	 for	 high-throughput	 screening,	 taking	 over	 2	 hours	 to	
measure	 the	 binding	 of	 one	 Ru(II)(bpy)3	 complex	 to	 cyt	 c	 in	 triplicate,	 therefore	 it	was	
decided	 to	 develop	 the	 assay	 for	 use	 on	 a	 fluorescence	 plate	 reader.	 The	 use	 of	 a	
fluorometer	allows	for	the	use	of	quartz	cuvettes,	which	have	very	 little	 interaction	with	
the	 components	 of	 the	 assay,	 as	 compared	 to	 the	 plastic	 plates	 used	 in	 conventional	




isotherm	 (Figure	 2.5a),	 indicating	 interactions	 between	 the	 plate	 and	 cyt	 c	 or	 the	
Ru(II)(bpy)3	 complex.	 This	 showed	 an	 additive	 to	 disrupt	 the	 interaction	 between	 the	
plate	and	the	assay	components	was	required.		
Two	 commonly	 used	 buffer	 additives	 to	 disrupt	 these	 interactions	 are	 the	 detergent	
Tween20	and	the	blocking	agent	bovine	serum	albumin	(BSA).	Assays	with	these	different	

























binding	 affinities	 of	 the	 different	 Ru(II)(bpy)3	 complexes	 synthesised	 were	 assessed	
(Table	 2.3).	 As	 can	 be	 seen	 Ru(II)(bpy)3	 complex	 26	 with	 24	 carboxylic	 acids	 has	 the	
highest	 binding	 affinity,	 the	 two	 Ru(II)(bpy)3	 complexes	31	 and	 32	 with	 12	 carboxylic	
acids	 have	 lower	 affinity,	 but	 similar	 affinities	 to	 each	 other,	 the	 two	 Ru(II)(bpy)3	
complexes	29	and	30	with	6	carboxylic	acids	bind	with	much	lower	affinity,	and	the	two	


























accompanied	with	 the	appearance	of	 a	UV/Vis	 absorbance	peak	at	550	nm.	 	The	 rate	of	
	 33	
reduction	can	thus	be	seen	using	a	UV/Vis	spectrometer	by	measuring	the	absorption	at	
550	nm	over	 time.	 	 The	binding	of	 a	molecule	 to	 the	 surface	of	 cyt	 c,	 close	 to	 the	haem	









The	work	 presented	 in	 this	 section	was	 performed	 by	 Dr.	Maria	 Filby,	 aided	 by	 Dr.	
Michael	Webb.		
Previously	 these	Ru(II)(bpy)3	complexes	had	been	hypothesised	 to	bind	at	 the	haem	
exposed	edge	of	cyt	c,	due	to	the	location	of	the	basic	amino	acid	residues	and	the	reduced	







In	 order	 to	 test	 this	 hypothesis	 the	 fluorescence	 spectra	 of	 Zn-substituted	 CCP	was	
taken	 alone,	 and	 when	 bound	 to	 cyt	 c	 (Figure	 2.7a).	 Upon	 addition	 of	 cyt	 c,	 the	
fluorescence	band	of	CCP	at	~580	nm	was	quenched.	On	addition	of	Ru(II)(bpy)3	complex	
26	 to	 this	cyt	c/CCP	complex	 the	 fluorescence	band	at	580	nm	was	restored,	along	with	
	 34	
giving	 the	 appearance	 of	 the	 Ru(II)(bpy)3	 complex	 26	 luminescence	 emission	 band	 at	
~635	 nm.	 This	 luminescence	 band	 at	 ~635	 nm	 is	 however	 quenched	 compared	 to	 the	





of	 cyt	 c	 to	 the	 cathode,	 but	 the	CCP	 is	 less	 affected	 (Lane	5).	 Thus,	 again,	 indicating	 the	
Ru(II)(bpy)3	complex	26	binds	to	cyt	c,	inhibiting	the	cyt	c/CCP	interaction.	
2.6 Binding	in	different	conditions	
Previously	 protein	 surface	 mimetics,	 including	 Ru(II)(bpy)3	 complexes,	 have	 been	
designed	 for	 binding	 to	 cyt	 c	 with	 charge-charge	 complementarity	 in	 mind,	 designing	
scaffolds	 functionalised	 with	 carboxylic	 acids	 in	 order	 to	 bind	 to	 the	 basic	 amino	 acid	
residues	on	cyt	c.	However	little	information	has	been	obtained	as	to	how	these	molecules	









Binding	 of	 Ru(II)(bpy)3	 complexes	 26	 and	 31,	 using	 the	 luminescence	 quenching	
assay,	 was	 tested	 at	 different	 temperatures.	 This	 allows	 a	 van’t	 Hoff	 analysis	 to	 be	
performed	 (Eq.	 2.3)	 to	 determine	 the	 thermodynamic	 parameters	 of	 binding.	 The	 van’t	
Hoff	equation	is	derived	from	the	Gibbs	free	energy	definition	(Eq.	2.1)	and	the	Gibbs	free	
energy	 isotherm	 equations	 (Eq.	 2.2),	 where	 ΔH	 and	 ΔS	 are	 assumed	 to	 be	 temperature	
independent.	
	 	 	 𝛥𝐺 = 𝛥𝐻 − 𝑇𝛥𝑆	 						 	 	 	 Eq.	2.1	
	 	 	 𝛥𝐺 = −𝑅𝑇𝑙𝑛𝐾																																																																												Eq.	2.2	
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	 31	 26	 CCP155	
ΔH/	kJ	mol-1	 -6.6	±	0.4	 -26.3	±	3.0	 9.4	±	0.8	
TΔS	(25	°C)	/	kJ	mol-1	 24.5	±	0.4	 16.0	±	3.0	 38.4	±	0.9	




whereas	 the	 binding	 of	 Ru(II)(bpy)3	 complex	 26	 is	 both	 entropically	 and	 enthalpically	









of	 Ru(II)(bpy)3	 complexes	26	 and	31	 were	 determined	 at	 different	 ionic	 strengthes	 (I).	
The	 binding	 of	 both	 Ru(II)(bpy)3	 complexes	26	 and	 31	 is	 highly	 dependent	 upon	 ionic	
strength	 (Table	 2.5)	 with	 binding	 affinity	 decreasing	 with	 increasing	 ionic	 strength,	
suggesting	electrostatic	contributions	dominate	the	binding	of	both	of	these	Ru(II)(bpy)3	
complexes	 to	 cyt	 c,	 as	 would	 be	 expected.	 The	 binding	 of	 CCP	 to	 cyt	 c	 is	 also	 highly	












and	 derivation	 of	 this	 is	 presented	 in	 the	 Appendix	 I)	 (Figure	 2.9)	 in	 this	 case	 using	 a	
Güntelberg	approximation	(Eq.	2.5),	which	is	valid	up	to	I	=	100	mM.		








From	 this	 relationship	 the	parameters	Kd0	 and	Z1Z2	 can	be	 established,	providing	an	
estimate	 of	 the	 binding	 affinity	 at	 I	 =	 0	 and	 the	 product	 of	 the	 interacting	 positive	 and	
negative	 charges,	 respectively.	 The	 data	 were	 consistent	 with	 the	 Güntelberg	
approximation	for	both	Ru(II)(bpy)3	complexes	(Figure	2.9),	giving	a	linear	relationship.	









	 31	 26	 CCP154	
Kd0	/	nM	 253	±	5	 1.11	±	0.21	 40.7	±	23.0	
Z1Z2	 25.9	±	1.9	 35.6	±	1.3	 28.8	±	4.8	
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The	Z1Z2	value	provides	an	 indication	of	 the	charges	 involved	 in	the	 interaction,	with	
Ru(II)(bpy)3	 complex	 26	 having	 a	 larger	 value	 than	 Ru(II)(bpy)3	 complex	 31	 and	 CCP.	
Using	 these	 data,	 the	 charge	 on	 the	 Ru(II)(bpy)3	 complex	 interacting	 with	 cyt	 c	 can	 be	
estimated.	 Assuming	 cyt	 c	 has	 the	 same	 charge	 in	 all	 cases	 (calculated	 to	 be	 ~6	 at	 pH	
7.5),158	the	charge	on	Ru(II)(bpy)3	complex	26	and	31	and	CCP	can	be	calculated	to	be	5.9,	
4.3	and	4.8,	respectively.	Ru(II)(bpy)3	complex	31	and	CCP	have	relatively	similar	charges,	
indicating	 similar	 interactions	 with	 cyt	 c,	 further	 showing	 that	 its	 binding	 to	 cyt	 c	 is	
mimicking	that	of	the	native	PPI.	Ru(II)(bpy)3	complex	26	has	a	larger	charge,	 indicating	
increased	electrostatic	 interactions	with	cyt	c,	 showing	 that	 it	 is	possible	 to	 increase	 the	
interactions	 in	 a	 native	 PPI,	 in	 order	 to	 gain	 high	 affinity	 protein	 surface	 ligands.	
Accounting	 for	 the	 crudeness	 of	 the	 Debye-Hückel	 approximation	 where	 small	 (~3	 Å),	
evenly	dispersed	charges	are	assumed	(even	when	using	the	Güntelberg	extension,	which	
extends	past	the	single	point	charges	used	in	the	first	(Debye-Hückel)	approximation),	the	
data	 indicate	 that	 perhaps	 not	 all	 the	 carboxylates	 are	 deprotonated	 under	 the	 assay	
conditions	(pH	7.5)	and/or	that	a	 limited	number	of	 the	carboxylates	are	needed	for	the	







The	 binding	 in	 different	 buffers	 can	 also	 give	 a	 further	 indication	 as	 to	 what	
interactions	are	important	for	binding,	as	for	binding	to	occur,	negatively	charged	anions	
must	 be	 displaced	 from	 the	 positively	 charged	 surface	 of	 cyt	 c,	 and	 positively	 charged	




















































































in	 sodium	 and	 potassium	 phosphate	 buffer,	 indicating	 the	 interactions	 of	 the	 cationic	
buffer	components	with	the	Ru(II)(bpy)3	complex	26	are	not	significant.	There	also	is	not	
a	significant	difference	between	the	binding	in	the	phosphate	buffers	and	the	sulfonic	acid	
buffers	 (MOPS	 and	 HEPES),	 suggesting	 that	 the	 nature	 of	 the	 anion,	 and	 the	
hydrophobicity	 of	 the	 buffer	 are	 not	 significant.	 This	 reinforces	 the	 conclusions	 of	 the	
Debye-Hückel	 analysis,	 with	 the	 interaction	 being	 dominated	 by	 electrostatic	
contributions.	For	the	tris	buffers	(btp	and	tris)	a	small	decrease	in	binding	affinity	is	seen	
compared	 to	 the	 other	 buffers;	 this	 is	 likely	 due	 to	 different	 interactions	 between	 the	
buffer	 and	 cyt	 c,	 and	 Ru(II)(bpy)3	 complex	 26	 and	 its	 chloride	 counterion.	 Both	 the	
ammonium	and	hydroxyl	functionalities	of	the	tris	buffers	may	interact	with	cyt	c	and	the	




Cyt	c	 is	 a	 stable	protein	 that	 does	not	 unfold	 over	 a	wide	 range	of	 pHs,	 however	 its	
ionisation	 state	 is	 affected	 by	 pH	 (Figure	 2.11b),159	 hence	 the	 pH	 of	 the	 solution	 is	
expected	 to	 affect	 the	 interaction	of	 cyt	c	with	 the	Ru(II)(bpy)3	 complexes,	 especially	 as	




The	 binding	 affinity	 follows	 an	 inverted	 bell	 shaped	 profile	 (Figure	 2.11a),	 which	












changing	 their	 role	 in	 the	 binding	 interaction.	 The	 amino	 acid	 residues	 that	 become	
protonated/deprotonated	 at	 pH	 6.5	 and	 9.0	 are	His-33	 and	 Lys-79	 respectively	 (Figure	
2.11c).159	 Lys-79	 is	 located	 on	 the	 haem-exposed	 edge,	 where	 binding	 of	 Ru(II)(bpy)3	
complex	26	 is	hypothesised	to	occur,	whereas	His-33	is	on	the	distal	 face	of	cyt	c.	There	




protonation	 state	 of	 Ru(II)(bpy)3	 complex	26	 is	 changed	 at	 pH	 6.5,	 affecting	 its	 binding	











is	 possible	 to	 draw	 some	 conclusions	 as	 to	 how	 the	 Ru(II)(bpy)3	 complexes	26	 and	 31	
bind	to	cyt	c.	The	binding	for	both	Ru(II)(bpy)3	complexes	is	electrostatically	driven,	with	
the	 binding	 of	 Ru(II)(bpy)3	 complex	 31	 being	 entropically	 favourable	 and	 that	 of	
Ru(II)(bpy)3	complex	26	being	both	entropically	and	enthalpically	favourable.	Compared	
to	 the	 native	 cyt	 c/CCP	 interaction,	 an	 entropy	 controlled,	 electrostatic	 interaction,	 the	
binding	 of	 Ru(II)(bpy)3	 complex	 31	 acts	 as	 a	 closer	 mimic.	 Increased	 enthalpic	
contributions	 for	 the	 binding	 of	 Ru(II)(bpy)3	 complex	 26	 arise	 from	 increased	
electrostatic	interactions	due	to	an	increased	number	of	carboxylates,	allowing	for	further	
interactions	over	that	in	the	native	PPI.	This	shows	it	may	be	possible	to	use	information	
on	 the	 binding	 interface	 of	 a	 known	 PPI,	 and	 enhance	 the	 interactions	 present	 when	
designing	a	molecular	ligand	in	order	to	gain	a	high	affinity	protein	surface	mimetic.	
2.7 NMR	spectroscopy	






interaction	 protein	NMR	 spectroscopy	was	 performed.	 	 	 In	 this	 case	 a	 1H-15N	HSQC	was	
used,	 where	 the	 backbone	 amide	 bond	 N-H	 cross-correlations	 are	 monitored,	 and	 the	
spectrum	 of	 cyt	 c	 with	 and	 without	 the	 Ru(II)(bpy)3	 complex	 present	 compared.	 The	






The	Astbury	Centre	had	 recently	 acquired	 a	new	950	MHz	NMR	 spectrometer	 so	 it	was	
decided	 to	 see	 if	 this	machine	 could	 detect	 naturally	 abundant	 levels	 of	 15N	 in	 an	HSQC	
experiment,	both	as	a	test	for	the	instrument	and	to	see	if	it	was	possible	to	detect	binding	
of	the	Ru(II)(bpy)3	complexes	to	cyt	c.	 	Cyt	c	 is	a	good	test	for	this	capability	as	it	can	be	
bought	 in	 large	 (gram)	 quantities,	 and	 studied	 in	 high	 (millimolar)	 concentration	
solutions,	 as	 is	 required	 for	 the	 detection	 of	 the	 low	 natural	 abundance	 of	 15N.	 	 NMR	
spectra	were	obtained	with	the	help	of	Dr.	Lars	Kuhn	and	Dr.	Arnout	Kalverda.	
2.7.1 Oxidised/reduced	cyt	c	
One	 problem	 that	 could	 be	 observed	 in	 the	 NMR	 spectrum	 of	 cyt	 c	 is	 due	 to	 the	
presence	 of	 the	 haem	 iron.	 In	 the	 oxidised	 Fe(III)	 state	 present	 in	 normal,	 oxygen-rich,	
conditions	 the	 Fe(III)	 has	 a	 d5	 high	 spin	 electronic	 configuration;	 this	 has	 unpaired	







As	 a	 different	 buffer	 and	 oxidation	 state	 of	 cyt	 c	 was	 going	 to	 be	 used	 in	 the	 NMR	
spectroscopy	 experiment,	 the	 binding	 of	 Ru(II)(bpy)3	 complex	 26	 to	 cyt	 c	 under	 the	
reducing	conditions	was	tested.	A	comparison	was	also	made	between	chemically	oxidised	
cyt	c	and	reduced	cyt	c	in	the	same	buffer	in	order	to	see	the	effect	cyt	c	reduction	has	on	















binding	 affinity	 is	 relatively	weak	 it	was	 decided	 to	 assess	 this	 binding	 in	 a	 lower	 ionic	
strength	 buffer	 to	 allow	 for	 the	 use	 of	 this	 cyt	 c	 stock.	 As	 can	 be	 seen	 in	Table	 2.8	 the	








Following	 a	 promising	 1H	 1-D	 spectrum	 (Figure	 2.12a)	 of	 2	mM	 cyt	 c	 in	 the	 5	mM	
sodium	phosphate,	2	mM	sodium	ascorbate,	10	%	D2O,	pH	7.3	buffer,	a	1H-15N	HSQC	was	
obtained.	This	gave	clearly	defined	cross-peaks	 (Figure	 2.12b)	which	could	be	assigned	
using	 a	 previously	 reported	HSQC	 assignment.161	 This	 shows	 the	 utility	 of	 the	 950	MHz	























indicates	 the	presence	of	protein-ligand	 interactions.	These	 chemical	 shift	 changes	were	
mapped	onto	 the	structure	of	 cyt	c	where	 they	 indicate	binding	 to	one	side	of	 the	haem	
group	of	cyt	c,	with	 the	opposite	 face	having	very	 few	amino	acid	residues	with	sizeable	
shifts	in	their	HSQC	cross-peaks	(Figure	2.13c),	indicating	a	binding	site	to	one	side	of	the	
haem	 exposed	 edge.	 The	 binding	 site	 identified	 here	 is	 in	 a	 similar	 location	 to	 that	 of	
carboxylate	 functionalised	 porphyrins,	 as	 determined	 by	 the	 Crowley	 group.26	 Mapping	
these	amino	acid	residues	onto	the	cyt	c/CCP	PPI	structure	(Figure	2.13d)	it	can	be	seen	
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1H-15N	HSQC	of	 cyt	 c	with	0.5	 equivalents	 of	Ru(II)(bpy)3	 complex	26,	 only	41	%	of	 the	
cross-peaks	 (Figure	 2.14b)	 present	 in	 the	 cyt	 c	 alone	 were	 present	 in	 the	 spectrum,	
compared	 to	 93	 %	 with	 0.5	 eq.	 of	 Ru(II)(bpy)3	 complex	 31.	 This	 means	 that	 detailed	
information	 as	 to	 the	 binding	 site	 could	 not	 be	 gleaned,	 for	 example	 a	 view	 of	 the	
Ru(II)(bpy)3	 complex	 31	 binding	 site	 is	 shown	 in	 Figure	 2.14c,	 with	 the	 shifts	 for	
Ru(II)(bpy)3	complex	26	shown	as	varying	colours	dependent	on	shift	difference,	and	blue	









Further	evidence	 for	multiple	binding	sites	 for	Ru(II)(bpy)3	 complex	26	 on	cyt	c	has	






binding	 of	 Ru(II)(bpy)3	 complex	26	 to	 the	S.	 cerevisiae	cyt	 c,	 a	 different	 shaped	 binding	





The	 synthesis	 and	 cyt	 c	 binding	 of	 7	 different	 Ru(II)(bpy)3	 complexes	 has	 been	
established.	A	 luminescence	quenching	assay	was	used	to	show	that	 increasing	numbers	
of	 carboxylates	 correlate	with	 increased	 cyt	 c	 binding	 affinity.	 A	UV/Vis	 cyt	 c	 reduction	
assay	corroborated	these	result.	 	The	binding	of	 two	of	 these	Ru(II)(bpy)3	complexes	26	






increased	 numbers	 of	 electrostatic	 interactions.	 Natural	 abundance	 1H-15N	 HSQC	 NMR	
spectra	were	obtained	 for	both	 cyt	c	 alone	and	Ru(II)(bpy)3	 complex	31	 bound	 to	 cyt	c,	
showing	 binding	 occurring	 at	 the	 cyt	 c/CCP	 binding	 interface,	 and	 indicating	 that	 the	
binding	of	Ru(II)(bpy)3	complex	31	to	cyt	c	does	indeed	mimic	that	of	CCP.	This	shows	that	
using	 known	 information	 about	 a	 native	 PPI	 it	 is	 possible	 to	mimic	 the	 PPI	 in	 order	 to	
achieve	 ligands	 for	 one	 of	 the	 protein	 partners.	 The	 enhanced	 binding	 of	 Ru(II)(bpy)3	
complex	26,	shows	it	is	possible	to	enhance	the	known	binding	interactions	present	in	the	




3 Design	 of	 multivalent	 Ru(II)(bpy)3	 and	 porphyrin	
scaffolds	for	dynamic	combinatorial	chemistry	
Dynamic	 combinatorial	 chemistry	 (DCC)	 is	 an	 approach	 whereby	 a	 thermodynamic	
equilibrium	of	many	competing	reversible	chemical	reactions	 is	generated,	which	can	be	
exploited	 for	 receptor	 discovery.	 The	 equilibrium	 is	 established,	 in	 the	 presence	 and	
absence	 of	 a	 template,	 in	 order	 to	 determine	 which	 compounds	 out	 of	 the	 dynamic	
combinatorial	 library	(DCL)	generated	are	amplified	and	therefore	bind	to	 that	 template	
(Figure	3.1).162–165	If	a	protein	template	is	used,	ligands	for	that	protein	template	may	be	
generated,	with	the	highest	affinity	ligands	being	amplified,	in	the	presence	of	the	protein,	











affinity	 around	 the	 protein	 surface	 mimetic	 scaffold,	 thus	 allowing	 the	 development	 of	
structurally	and	compositionally	diverse	protein	surface	mimetics.	To	this	end,	the	design	
of	 Ru(II)(bpy)3	 complex	 and	 tetraphenyl-porphyrin	 DCC	 scaffolds	 has	 been	 attempted,	






As	 the	 aim	 of	 using	 these	 multivalent	 dynamic	 systems	 is	 to	 generate	 multivalent	
protein	 ligands,	 the	 system	must	 be	 biologically	 compatible.	 For	 DCC	 to	 be	 biologically	
compatible,	the	reactions	must	be	performed	in	an	aqueous	environment,	at	neutral	pH,	at	

















these	 use	 the	 same	 types	 of	 linkages	 with	 imines	 and	 various	 sulfur	 containing	 bonds	
being	common.	
DCLs	 have	 also	 been	 designed	 where	 the	 system	 is	 first	 equilibrated	 in	 a	 non-
biologically	 relevant	 context,	 and	 the	 mixture	 of	 products	 obtained	 tested	 against	 the	
biological	 molecule	 of	 interest.	 The	 procedure	 can	 then	 be	 repeated	 with	 different	




















































































and	 de	 Mendoza	 groups	 described	 in	 the	 Chapter	 1,131,132	 was	 developed,173	 but	 this	
methodology	 did	 not	 prove	 to	 be	 reproducible.	 Therefore	 a	 different	 type	 of	 reversible	
reaction,	 was	 attempted	 around	 a	 Ru(II)(bpy)3	 core.	 The	 multivalent	 nature	 of	 the	
scaffolds	mean	that	the	use	of	thiol-based	DCC	would	be	problematic	due	to	the	potential	
for	 polymerisation	 of	 the	 scaffold	 by	 disulfide	 bond	 formation.	 Acyl	 hydrazones	 were	
chosen	 as	 they	 do	 not	 require	 a	 fixation	 reaction	 at	 the	 end	 of	 the	 DCL	 generation,	 as	
required,	 for	 example,	 for	 imine	 formation.	Acyl	 hydrazides	 are	 also	 facile	 to	 synthesise	






A	 hydrazide	 Ru(II)(bpy)3	 scaffold	 43,	 initially	 directly	 attached	 to	 the	 Ru(II)(bpy)3	
core	was	chosen	as	a	good	starting	point.	This	would	allow	for	6	different	hydrazones	to	





































































Hydrazides	 can	 readily	 be	 formed	by	 the	 reaction	 of	 hydrazine	monohydrate	with	 a	
methyl	or	ethyl	ester.	Initially	this	was	attempted	on	the	methyl	ester	ligand	47	(Scheme	
3.2	 top),	however	the	hydrazide	ligand	48	 formed	was	only	soluble	 in	very	strong	acids,	
preventing	further	reaction	to	form	the	hydrazide	Ru(II)(bpy)3	complex	43.	The	hydrazide	
Ru(II)(bpy)3	 complex	 43,	 however,	 could	 easily	 be	 formed	 from	 the	 methyl	 ester	




the	 period	 of	 a	 few	 hours,	 thus	 this	 compound	 could	 not	 be	 stored.	 Degradation	 of	













































































Various	 hydrazone	 Ru(II)(bpy)3	 complexes	 could	 be	 formed	 from	 the	 hydrazide	
Ru(II)(bpy)3	complex	43	(Scheme	3.3),	with	almost	immediate	reaction	on	addition	of	the	
appropriate	aldehyde	44.	Benzaldehyde	derivatives	were	used	as	they	lack	α-protons	and	





Prior	 to	 the	 generation	 of	 a	 complex	 DCL	 it	 was	 necessary	 to	 show	 that	 hydrazone	
exchange	 occurs.	 High	 resolution	 mass	 spectrometry	 (HRMS)	 was	 used	 to	 show	 this	
exchange,	 as	 it	 requires	 very	 little	material	 and	measurements	 can	 be	 taken	 at	 various	









Obtaining	 the	 mass	 spectrum	 of	 the	 various	 different	 hydrazone	 Ru(II)(bpy)3	
complexes	46	 formed	revealed	the	M2+	ion	peak	as	expected,	but	also	revealed	peaks	for	
radical	 degradation	 of	 the	 Ru(II)(bpy)3	 complex	 in	 the	 mass	 spectrometer,	 through	
cleavage	 of	 the	 N-N	 bond	 (Scheme	 3.4).	 This	 ties	 in	 well	 with	 the	 instability	 of	 the	
hydrazide	Ru(II)(bpy)3	 complex	 in	oxygen	as	 this	 also	 relies	on	 the	breaking	of	 the	N-N	
bond	using	an	oxygen	single	electron.	Knowledge	of	this,	however,	allows	all	peaks	in	the	
mass	spectrum	can	be	assigned.	

























species	 from	 one	 hydrazone	 exchange	 (1)	 at	 first	 increased,	 and	 then	 decreased.	 The	
species	 from	 subsequent	 hydrazone	 exchanges	 (2,	 3,	 4	 etc.)	 increased	 over	 time	 at	
decreasing	 rates	 for	 later	 hydrazone	 exchanges.	 However,	 the	 system	 did	 not	 reach	
thermodynamic	equilibrium	after	32	hours,	as	this	would	result	in	the	proportion	of	each	
species	remaining	constant	(flat-lining),	which	was	not	observed.	In	terms	of	a	biological	
system,	 the	use	of	such	a	system	would	 take	 too	 long,	and	 the	protein	would	potentially	
not	 be	 stable	 for	 this	 length	 of	 time.	 Incubation	 of	 the	 same	 system	without	 a	 catalyst	





























































The	 N-N	 bond	 cleavage	 in	 the	 mass	 spectrometer	 was	 hypothesised	 to	 be	 due	 to	












DMF,	 while	 the	 initial	 Ru(II)(bpy)3	 complex	 scaffold	 hydrazones	 46	 were	 soluble	 in	
water/acetonitrile	mixtures.	Upon	attempts	to	dilute	DMSO	stocks	of	the	new	hydrazone	
Ru(II)(bpy)3	complexes	50	 into	water	and	various	buffers	in	the	concentrations	required	
for	 HRMS	 analysis,	 precipitation	was	 observed	 until	 50	%	 DMSO	was	 used,	 even	when	













































































































The	 syntheses	 previously	 described,	 in	 Chapter	 2,	 involve	 the	 synthesis	 of	 separate	
ligands	and	protected	Ru(II)(bpy)3	complexes	 for	each	of	 the	 functionalised	Ru(II)(bpy)3	
complexes	required		(Figure	3.3a).	However,	especially	for	the	synthesis	of	a	wide	range	
of	Ru(II)(bpy)3	 complexes,	 it	would	be	useful	 to	 use	 a	more	divergent	 route,	whereby	 a	













































react	more	readily	with	 the	peptide	coupling	agents.	 	However,	 these	also	did	not	prove	
fruitful.	These	reactions	were	also	difficult	to	follow:	it	was	found	that	all	the	Ru(II)(bpy)3	
complexes,	 except	 the	 expected	 final	 Ru(II)(bpy)3	 complexes	 52	 and	 53	 stuck	 to	 the	
baseline	 of	 the	 TLC	 plate.	 Similarly	 LCMS	 did	 not	 prove	 helpful	 as	 the	 starting	 (and	

































































a) HATU, DMF, DIPEA, 
14 days
b) HCTU, DMF, DIPEA,
   60 oC, 5 days
c) PyBOP, DMF, DIPEA



































29	 and	use	 this	 to	 form	amide	bonds.	This	 route	 (Scheme	 3.9)	worked	well,	 giving	 the	




also	 proved	 to	 be	 easier	 to	 purify;	 so	 long	 as	 the	 amine	 38	 could	 be	 removed	 by	 acid	
washes,	only	 the	 fully	 functionalised	Ru(II)(bpy)3	complex	41	moved	off	 the	baseline	on	
the	 TLC	 plate	 in	 10	%	methanol	 in	 dichloromethane.	 This	 is	 compared	 to	 the	 products	
from	ruthenium(II)	complexation	from	the	previous	methodology	where	the	Ru(II)(bpy)3	
complexes	41	 needed	 to	 be	 separated	 from	 the	 ligands	42	which	 often	 had	 similar	Rf.s.			
This	meant	 that	 the	 column	purification	was	much	quicker,	 so	 removal	of	 acid-sensitive	
protecting	groups	as	seen	with	some	of	 the	 larger	Ru(II)(bpy)3	complexes	41c	 and	 e	on	
silica	was	not	observed.			
There	 were	 some	 disadvantages	 to	 this	 new	 synthetic	 route;	 the	 yields	 were	much	
lower	than	that	for	ligand	formation	prior	to	ruthenium(II)	complexation,	presumably	due	
to	the	requirement	for	6	amide	bond	formations	on	the	Ru(II)(bpy)3	complex	29	to	form	
the	 desired	 product	 as	 opposed	 to	 2	 amide	 bond	 formations	 on	 the	 bpy	 ligand	 40.	
However,	 the	 advantage	 of	 being	 able	 to	 form	 small	 quantities	 of	 many	 Ru(II)(bpy)3	























































Synthetic	methods	 for	 the	 synthesis	 of	 both	 4’	 and	 5’	monosubstituted	 Ru(II)(bpy)3	
complexes	 have	 also	 been	 studied,	 these	 are	 presented	 in	Appendix	 II.	 The	 synthesis	 of	
these	 lower	 functionality	 Ru(II)(bpy)3	 complexes	 offer	 the	 potential	 advantage	 of	 less	








increasing	 the	 solubility	 of	 the	 core	 Ru(II)(bpy)3	 complex	 scaffold.	 It	 was	 decided	 to	
change	 the	glycine	 linker	 in	50	 to	serine	(54),	aspartic	acid	(55)	and	glutamic	acid	(56)	
(Figure	3.4),	 introducing	hydroxyl	or	carboxylic	acid	groups	to	potentially	solubilise	the	
whole	Ru(II)(bpy)3	complex	scaffold.		
The	 addition	 of	 the	 acid	 groups	 also	 had	 the	 potential	 advantage	 of	 facilitating	 the	
hydrazone	 exchange	 by	 neighbouring	 group	 participation.	 So	 far	 nucleophilic	 catalysts	
(aniline)	 for	 catalysing	 the	 hydrazone	 exchange	 at	 neutral	 pH,	 have	 been	 discussed,	
however	 hydrazone	 exchange	 can	 also	 be	 catalysed	 by	 acid,	 and	 indeed	 ortho-carboxy	
phenylhydrazine	has	been	shown	to	increase	the	rate	of	hydrazone	formation,	compared	































































































n = 1 55
n = 2 56
	 60	





Initially	 orthogonally	 protected	 serine	 and	 aspartic	 acid	 functionalised	 Ru(II)(bpy)3	
complexes	 41j	 and	 k	 were	 synthesised	 (Scheme	 3.10),	 using	 the	 new	 synthetic	
methodology.	 	 From	 these	 Ru(II)(bpy)3	 complexes	 there	 are	 two	 further	 reactions	
required	to	synthesise	the	desired	hydrazide	Ru(II)(bpy)3	complexes	54	and	55,	these	are:	
i)	 tert-butyl	 deprotection	 of	 the	 hydroxyl/carboxylic	 acid	 side	 chains	 and	 ii)	 hydrazide	





(with	58b)	were	observed.	Attempts	at	 first	making	 the	hydrazide	 functionality,	 yielded	
less	amide	bond	cleavage	on	the	serine	Ru(II)(bpy)3	complex	41j,	however,	as	there	was	
still	observable	amide	bond	cleavage	a	clean	sample	of	the	Ru(II)(bpy)3	complex	57j	could	
not	 be	 obtained.	 With	 the	 aspartic	 acid	 Ru(II)(bpy)3	 complex	 41k	 the	 reaction	 with	
hydrazine	 monohydrate,	 again	 yielded	 degradation.	 Similar	 attempts	 at	 the	 hydrazide	
















































































































































































the	 intact	 acid	 functionalised	 Ru(II)(bpy)3	 complex	 core	 29	 (Scheme	 3.13a).	 Attempts	





65	 (synthesis	 of	 these	 acid	 functionalised	 monosubstituted	 Ru(II)(bpy)3	 complexes	 64	
































































































































































































Due	 to	 the	 degradation	 problems	 experienced	 in	 the	 synthesis	 of	 the	 hydrazide	
Ru(II)(bpy)3	 complexes	 54,	 55	 and	 56,	 a	 different	 multivalent	 hydrazide	 scaffold	 was	








































































groups	 as	 opposed	 to	 the	6	with	 the	disubtituted	Ru(II)(bpy)3	complexes	 (Figure	 3.5b),	
potentially	making	the	analysis	less	challenging,	ii)	the	porphyrins	primarily	ionise	as	+1	
rather	 than	 +2	 species	 separating	 the	 peaks	 in	 the	 mass	 spectrum,	 and	 iii)	 there	 is	 no	
multi-isotopic	metal	 ion,	 decreasing	 the	 isotopic	 pattern	window	 in	 the	mass	 spectrum,	
potentially	increasing	signal	to	noise.	
3.3.1 Porphyrin	scaffold	design	and	synthesis	





in	 the	mass	 spectrometer	 it	was	 decided	 not	 to	 pursue	 this	 scaffold	 any	 further,	 and	 to	







Ru(II)(bpy)3	 complex	 49,	 was	 chosen.	 To	 this	 end,	 an	 ethyl	 glycine	 porphyrin	 74	 was	
synthesised	(Scheme	3.15b),	and	subjected	to	hydrazide	formation	conditions.	This	gave	
a	 very	 insoluble	 purple	 solid,	 which	 was	 hypothesised	 to	 be	 the	 glycine	 hydrazide	
porphyrin	75	but	could	not	be	characterised	due	to	its	insolubility.	The	insolubility	of	the	
glycine	 hydrazide	 porphyrin	 75,	 is	 perhaps	 unsurprising	 given	 that	 the	 deprotected	




















ii) H2NNHBoc, CH2Cl2, 
















































































attempt	 to	 use	 a	 serine	 in	 place	 of	 the	 glycine	 to,	 as	 with	 the	 Ru(II)(bpy)3	 complexes,	
increase	the	scaffold	solubility.	A	serine	methyl	ester	amino	acid	62a	was	first	attached	to	
the	porphyrin	core	(Scheme	3.16),	however	this,	as	with	the	Ru(II)(bpy)3	complexes,	did	












































































see	 if	 it	 was	 possible	 to	 exchange	 the	 benzaldehyde	 moiety	 with	 other	 aldehydes	 44	
(Scheme	3.18).		The	benzaldehyde	hydrazone	porphyrins	79	were	soluble	in	10	%	DMSO	
in	 aqueous	 solutions,	 thus	 allowing	 attempts	 at	 hydrazone	 exchange	 to	 occur	 in	































































































difference	 in	 the	 ionisation	 of	 the	 different	 hydrazone	 Ru(II)(bpy)3	 complexes.	 This	
argument	 is	 not	 valid	 for	 the	 neutral	 porphyrins.	 However,	 much	 of	 the	 porphyrin	
ionisation	 is	 due	 to	 protonation	 of	 the	 central	 porphyrin	 core,	 but	 protonation	 of	 the	
peripheral	groups	will	now	also	be	more	 important.	This	means	 that	 the	mass	spectrum	























































































3.7b),	 in	 order	 to	 establish	 i)	 if	 hydrazone	 exchange	 occurred,	 ii)	 if	 equilibrium	 was	
reached	and	iii)	the	timescale	for	the	establishment	of	equilibrium.	
Considering	one	of	these	systems,	(aspartic	acid	hydrazone	porphyrin	79b	with	4-carboxy	




species	 for	 each	of	 the	 subsequent	hydrazone	exchanges,	 as	well	 as	peaks	 for	N-N	bond	
cleavage.	 Looking	 at	 just	 the	 protonated	 peaks,	 the	 progression	 of	 these	 hydrazone	
exchanges	 could	 be	 followed	 over	 time	 (Figure	 3.7b)	 with	 successive	 hydrazone	
exchanges	 being	 observed.	 The	 initial	 species	 79b	 (0)	 decreased	 over	 time,	 with	 the	


































Differing	 rates	 of	 hydrazone	 exchange	 were	 observed	 between	 the	 three	 porphyrin	
scaffolds	and	with	 the	different	aldehydes.	Generally	 the	glutamic	acid	and	aspartic	acid	
hydrazone	 porphyrins	79b	 and	 c	 (Figure	 3.8d,	 e,	 f,	 g,	 h	 and	 i)	 showed	 faster	 exchange	
rates	than	the	serine	hydrazone	porphyrin	79a	(Figure	3.8a,	b,	and	c).	This	supports	the	








However	 in	almost	all	 cases	equilibration	was	not	being	 reached	within	 the	24	hour	




As	 equilibration	 was	 not	 reached	 within	 24	 hours,	 the	 DCC	 systems	 were	 not	
completely	 suitable	 for	 protein	 templation.	 Different	 groups	 have	 reported	 the	 use	 of	
nucleophilic	 catalysts	 for	 use	 in	 hydrazone	 exchange	 reactions	 in	 biologically	 relevant	
media.168,176,177	 Aniline	 45	 was	 the	 initial	 catalyst	 reported,168	 and	 was	 the	 catalyst	





soluble	 and	 are	 less	 likely	 to	 degrade	 in	 DMSO	 compared	 to	 the	 phenylene	 diamines	
reported	 by	 Distefano	 et	 al.177	 Hydrazone	 exchange	 reactions	 to	 exchange	 the	
benzaldehyde	moiety	for	4-carboxy	benzaldehyde	44c	with	the	three	porphyrin	scaffolds	
79	(Figure	3.9)	were	carried	with	both	these	catalysts.	
As	 can	 be	 seen	 the	 two	 catalysts	 did	 increase	 the	 rate	 of	 equilibration	 in	 all	 cases.		
Comparing	the	aniline	45	and	anthranillic	acid	80	catalysts	 it	seems	the	 incubation	with	
aniline	45	 may	 have	 increased	 the	 rate	 slightly	 more	 than	 that	 of	 anthranillic	 acid	80,	
therefore	aniline	45	was	chosen	for	use	in	all	further	studies.		
Similar	attempts	to	establish	the	effects	of	catalysts	on	the	hydrazone	exchanges	with	2,4-
dimethoxy	 benzaldehyde	 44b	 and	 4-methyl	 ester	 benzaldehyde	 44f	 again	 showed	 the	
catalysts	increasing	the	rate	of	reaching	equilibrium.	Both	catalysts,	however,	could	not	be	
explored	 with	 these	 aldehydes,	 due	 to	 the	 formation	 of	 insoluble	 imines	 between	 the	













used	 very	 high	 aniline	 45	 loadings	 compared	 to	 both	 the	 aldehydes	 (2000	 eq.)	 and	
hydrazides	(500	eq.	per	hydrazide).	These	catalyst	loadings	are	much	higher	than	can	be	
used	 in	 this	 set	 up,	 due	 to	 solubility,	 however	 different	 concentrations	 of	 catalyst	 to	
	 75	
aldehyde	should	have	an	effect	on	the	rate,	especially	when	the	catalyst	concentrations	are	
similar	 to	 that	of	 the	aldehyde.	Attempts	were	made	at	different	aniline	45	 loadings,	 	on	
exchange	 reactions	 with	 2,4-dimethoxy	 benzaldehyde	 44b,	 for	 all	 three	 hydrazone	
porphyrin	scaffolds	79,	with	exemplary	results	for	the	aspartic	acid	hydrazone	porphyrin	
scaffold		79b	shown	in	Figure	3.10.	2,4-dimethoxy	benzaldehyde	44b	was	chosen	for	this	
study	 as	 it	 displayed	 the	 slowest	 rates	 of	 reaching	 equilibrium	 in	 the	 initial,	 no	 catalyst	
studies.	 The	 rate	 of	 reaching	 equilibrium	 was	 faster	 with	 increasing	 catalyst	





(Figure	 3.11)	 it	 was	 seen	 that	 under	 10	 mM	 aniline	 45	 concentration	 hydrazone	















Having	 shown	 that	 it	 was	 possible	 to	 exchange	 the	 benzaldehyde	 moiety	 for	 another	
aldehyde,	 it	was	necessary	 to	show	that	 the	system	did	not	reach	a	static	point	and	was	
indeed	 at	 a	 dynamic	 equilibrium.	 This	 was	 achieved	 by	 taking	 the	 established	 mixture	
from	incubation	with	25	equivalents	of	an	aldehyde	for	24	hours	then	adding	a	second	25	
equivalents	of	 the	 same	aldehyde	 to	 show	 if	 it	wass	possible	 to	perturb	 the	equilibrium	
(Figure	 3.12).	 This	 was	 attempted	 by	 considering	 just	 2	 time	 points,	 looking	 at	 the	
distributions	 following	 the	 first	 24	 hours	 incubation	 then	 24	 hours	 after	 the	 second	





1st 24 hour incubation 2nd 24 hour incubation











The	 addition	 of	 the	 second	 25	 equivalents	 of	 aldehyde	44c	 does	 indeed	 change	 the	
distribution	 for	 all	 three	porphyrin	 scaffolds	79	 (Figure	3.13).	With	 all	 three	hydrazone	
porphyrin	scaffolds	79	there	is	a	shift	to	more	hydrazone	exchanges	having	occurred,	with	
the	initial	species	(0)	decreasing	and	the	final	species	(4)	increasing,	along	with	changes	in	




Having	 shown	 that	 a	 dynamic	 equilibrium	 was	 indeed	 generated	 it	 was	 decided	 to	
incubate	 the	 system	with	 2	 different	 aldehydes,	 to	 look	 at	 the	 thermodynamic	mixture	
obtained.	Initially	this	was	attempted	using	the	single	time	point	method	described	above,	
looking	 at	 both	 mixtures	 that	 had	 been	 preincubated	 with	 one	 aldehyde	 followed	 by	
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addition	of	the	other	aldehyde	(Figure	3.14b)	as	well	as	ones	where	a	mixture	of	the	two	
aldehydes	 was	 present	 from	 the	 start	 (Figure	 3.14a).	 	 For	 these	 studies	 an	 aniline	45	












and	h)	 gave	 a	 similar	distribution	of	 products	 to	 that	without	pre-incubation	 and	direct	
























from	the	method	of	analysis,	 for	many	of	 these	species,	especially	with	 incubations	with	
two	aldehydes,	discerning	the	signal	 for	 the	species	present	above	the	noise	 in	 the	mass	
spectrum	could	be	difficult.	This	may	be	leading	to	the	larger	discrepancy	in	this	case,	as,	
especially	 in	this	system,	after	 the	total	48	hour	 incubation	the	signal	above	noise	 in	the	
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Having	 shown	 that	 a	 mixture	 of	 different	 hydrazone	 functionalised	 porphyrins	 do	
form	 on	 incubation	 with	 two	 aldehydes,	 the	 rate	 of	 forming	 this	 equilibrium	 was	
investigased,	as	in	the	case	of	pre-incubation	with	4-carboxy	benzaldehyde	44c,	the	rate	of	
reaching	the	dynamic	equilibrium	could	be	different	 to	 that	with	 just	one	aldehyde.	This	





and	 is	 a	 reasonable	 time	 for	 protein	 templation.	 Again,	 the	 species	 obtained	 from	 pre-
incubation	with	 2,4-dimethoxy	 benzaldehyde	44b	 and	 the	 species	 obtained	 from	 direct	
mixing	of	both	aldehydes	were	similar,	however	the	species	present	after	pre-incubation	
with	 4-carboxy	 benzaldehyde	 44c	 was	 somewhat	 different,	 though	 the	 system	 was	










After	 showing	 that	 hydrazone	 exchange	 to	 generate	 a	 dynamic	 equilibrium	 on	 the	
porphyrin	hydrazone	 scaffolds	79	was	possible,	 incubation	with	a	protein	 template	was	





Incubation	 of	 the	 three	 hydrazone	 porphyrin	 scaffolds	 79	 with	 2	 or	 3	 additional	













by	 addition	 of	 ammonium	hydroxide.	 Then	 the	 separation	 of	 protein	 and	 the	 porphyrin	
DCL	 was	 attempted,	 to	 allow	 for	 analysis.	 Initially	 this	 was	 attempted	 using	 protein	
concentrators	 (MWCO	5	kDa)	which	 theoretically	 should	 retain	 the	protein,	 and	not	 the	
porphyrin	DCL.	However,	the	porphyrins	stayed	in	the	protein	concentrator,	even	without	
any	 protein	 present.	 It	 was	 then	 attempted	 to	 precipitate	 the	 protein	 from	 the	 DCL	
mixture,	 using	 ice-cold	 ethanol	 and	 methanol/chloroform	 mixtures.	 These	 gave	 some	
precipitation	but	mass	 spectra	of	 the	 solutions	 left	 still	 showed	protein	present	 and	did	
not	allow	detection	of	the	porphyrin	DCL.	Analytical	HPLC	was	also	attempted	on	samples	
with	 no	 protein	 present,	 however	 due	 to	 the	 complex	 mixture	 of	 the	 DCL	 present	 the	






hydrazone	scaffold	46	 in	water/acetonitrile	mixtures.	However,	 attempts	at	making	 this	
system	 more	 biologically	 compatible	 did	 not	 prove	 fruitful	 with	 solubility	 and	
stability/degradation	issues.	In	the	process	of	this	study	a	new	synthetic	method	for	4,4’-
disubstituted	 Ru(II)(bpy)3	 complexes	 was	 developed,	 which	 could	 prove	 useful	 for	 the	
development	of	new	Ru(II)(bpy)3	complexes	for	a	variety	of	different	applications.	
Subsequently,	three	porphyrin	hydrazone	scaffolds	79	have	been	generated	which	are	
more	 soluble	 in	 biologically	 compatible	 media	 (10	 %	 DMSO	 in	 aqueous	 solutions).	
Hydrazone	exchange	reactions	were	performed	on	these	porphyrin	scaffolds	using	several	
aldehydes,	 following	 the	 reactions	 over	 time	 in	 order	 to	 gain	 insight	 into	 the	 rates	 of	
reaching	 equilibration.	 The	 effects	 of	 nucleophilic	 catalysis	 using	 aniline	 45	 and	
anthranillic	 acid	 80	 have	 been	 studied,	 showing	 addition	 of	 these	 catalysts	 lead	 to	
equilibration	 within	 12	 hours,	 giving	 a	 system	 capable	 of	 reaching	 equilibrium	 in	 a	
timeframe	 suitable	 for	 templation	 with	 biological	 molecules.	 The	 generation	 of	
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thermodynamic	mixtures	after	incubation	with	2	aldehydes	was	shown,	with	equilibration	
again	 occurring	 within	 12	 hours,	 giving	 a	 system	 prime	 for	 incubation	 with	 different	
protein.		












binding	 to	 many	 different	 smell	 receptors	 (Figure	 4.1),	 thus	 allowing	 discrimination	
between	the	different	smells.	Here	the	luminescent	responses	of	a	range	of	functionalised	






Sensing	 arrays	 have	 been	 widely	 reported	 for	 the	 discrimination	 of	 different	 metal	
ions,	 anions	 and	 various	 different	 small	 molecules.178	 Arrays	 for	 the	 sensing	 of	 large	
biomolecules,	 and	 cells,	 however,	 have	 been	 less	 widely	 reported,	 but	 present	 an	
interesting	 target	due	 to	 the	potential	 for	use	 in	multiple	applications,	 including	disease	
diagnosis,179,180	and	proteome	sensing.180–182	Traditional	approaches	for	the	discrimination	
of	proteins	are	relatively	limited	in	scope,	relying	on	enzymes	and	antibody	responses,	for	
example	 using	 enzyme-linked	 immunosorbent	 assays	 (ELISA),	 which	 are	 cumbersome,	
expensive	and	can	be	plagued	with	 false	results,	as	 illustrated	by	the	 fact	 that	a	study	of	





In	 an	 initial,	 proof-of-concept	 experiment,	 the	 Hamilton	 group	 used	 functionalized	
porphyrins	 to	discriminate	between	 cyt	 c,	myoglobin,	 cyt	 c551	 and	 feredoxin	 to	 generate	
fingerprint-like	 responses	 for	 each	 of	 the	 different	 proteins.95	 They	 then	 furthered	 their	
study	 by	 using	 a	 statistical	 analysis	 technique,	 linear	 discrimination	 analysis	 (LDA),	 to	
show	significant	discrimination	of	cyt	c,	lysozyme,	ferredoxin	and	α-lactalbumin.94,95		
The	 Anslyn	 group	 subsequently	 described	 discrimination	 of	 proteins	 and	
glycoproteins	 and	 some	 ‘within-protein-class’	 discrimination	 of	 proteins,184	 using	
combinatorially	 synthesised	 tripeptide	 and	 boronic	 acid	 functionalised	 hexasubstituted	
benzenes.	They	have	also	used	Zn(II)-(dpa)	complexes	to	discriminate	between	different	
classes	 of	 MAP	 kinases.185	 The	 Rotello	 group	 have	 used	 fluorescent	 polymers,181	
fluorescent	 polymer	 appended	 gold	 nanoparticle	 sensors,179,180	 and	 fluorescent	 protein-
appended	gold	nanoparticle180,186	for	the	detection	of	a	range	of	proteins,180–182	and	for	the	
detection	of	metastatic	cells.179,180	These	approaches	allowed	for	quantification	of	protein	








of	 proteins	 were	 incubated	 with	 a	 range	 of	 Ru(II)(bpy)3	 complexes	 (Figure	 4.2).	 The	
Ru(II)(bpy)3	complexes	possess	different	groups	around	the	periphery	and	present	these	















































































Eight	different	Ru(II)(bpy)3	 complexes	 (26,	29	 –	 32,	 34,	 35	 and	81)	 (Figure	 4.2)	were	
incubated	 with	 nine	 different	 proteins	 (lysozyme,	 α-chymotrypsin	 (α-ChT),	 horse	 cyt	 c,	
papain,	ribonuclease	(RNAse)	A,	bovine	serum	albumin	(BSA),	yeast	cyt	c,	hDM2	and	Mcl-
1)	 (Figure	 4.4).	 The	 luminescence	 intensity	 of	 each	 of	 the	 Ru(II)(bpy)3	complexes	with	



















necessary	 as	 the	 magnitude	 of	 the	 intensities	 of	 the	 Ru(II)(bpy)3	 complexes	 varies	
between	plates.	
For	 each	 of	 the	 proteins	 a	 fingerprint-like	 response	 (Figure	 4.5)	 with	 different	
luminescence	responses	from	each	of	the	Ru(II)(bpy)3	complexes	on	addition	of	different	
proteins	 was	 obtained.	 Most	 of	 the	 Ru(II)(bpy)3	 complexes	 show	 varying	 luminescence	





From	 the	 bar	 chart	 in	 Figure	 4.5c,	 it	 can	 be	 seen	 that	 there	 are	 differences	 in	
luminescence	 response	 to	 the	 individual	 proteins	 with	 the	 different	 Ru(II)(bpy)3	
complexes,	however	the	discrimination	of	 the	proteins,	by	eye,	 is	not	 trivial,	especially	 if	
the	 number	 of	 Ru(II)(bpy)3	 complexes	 or	 proteins	 were	 to	 be	 increased.	 Therefore	 it	
isnecessary	to	simplify	the	data	from	8	dimensional	data	(arising	from	the	8	Ru(II)(bpy)3	







Two	 different	 statistical	 techniques,	 principal	 component	 analysis	 (PCA)	 and	
discriminant	 analysis	 (DA),	 have	 been	 widely	 used	 in	 the	 literature	 for	 reducing	 the	
dimensionality	 of	 array	 data.188	 These	 two	 techniques	 generate	 score	 plots	 using	
combinations	of	the	original	data	on	each	of	the	axes,	 in	order	to	take	the	n-dimensional	
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data	 down	 to	 2	 or	 3	 dimensions,	 allowing	 the	 data	 to	 be	 plotted	 graphically	 (Figure	
4.6).188	Both	techniques	reduce	the	data	using	matrix	techniques,	finding	eigenvectors	and	
eigenvalues	 to	 describe	 new	 axes	 and	 the	 level	 of	 discrimination	 respectively.	 Matrix	
derivations	 and	 discussion	 of	 the	 mathematics	 behind	 the	 techniques	 are	 discussed	 in	
more	detail	in	Appendix	III.	
DA	 is	 a	 supervised	 statistical	method,189	meaning	 it	 uses	 a	 training	 set	 of	 data,	 and	
looks	for	the	best	way	of	organising	the	data	so	as	to	increase	the	discrimination	between	
classes	while	 decreasing	 the	 variation	within	 classes.	 PCA	 is	 unsupervised	 and	 looks	 at	
finding	 the	maximum	 variation	 between	 all	 the	 data,	 irrespective	 of	 the	 data	 classes.190	
This	means	that	DA	looks	for	clustering	of	classes	whereas	PCA	spreads	data	points	out	as	
much	 as	 possible.188	 As	 the	 ultimate	 aim	 with	 this	 analysis	 is	 to	 see	 if	 it	 is	 possible	 to	
cluster	 all	 the	 data	 from	 each	 protein,	 and	 separate	 that	 cluster	 from	 that	 of	 the	 other	
proteins,	discriminant	analysis	has	been	used.	
In	this	case	linear	discriminant	analysis	(LDA)	was	used,	taking	linear	combinations	of	
the	 original	 components	 as	 described	 earlier.	 This	 makes	 an	 assumption	 that	 all	 the	
covariance	matrices	for	all	the	different	classes	are	equivalent,	i.e.	how	much	the	data	for	a	
single	 protein/Ru(II)(bpy)3	 complex	 combination	 compares	 with	 another	
protein/Ru(II)(bpy)3	 complex	 combination	within	 the	 same	 replicate	 is	 the	 same	 across	
different	 replicates	 for	 the	 same	 protein.	 This	 means	 that	 it	 is	 assumed	 that	 the	
luminescence	responses	for	a	specific	Ru(II)(bpy)3	complex	with	a	protein	should	be	the	
same	 across	 replicates.	 Quadratic	 discriminant	 analysis	 (QDA)	 does	 not	 make	 this	





Initially	 a	 2-D	 LDA	 was	 performed	 (Figure	 4.7a)	 on	 the	 array	 data	 obtained.	 This	
showed	clear	and	distinct	clusters	for	the	two	cyt	c	proteins	(horse	heart	and	yeast	cyt	c).	
This	 is	 a	 promising	 result,	 as	 cyt	 c	 is	 a	 highly	 evolutionarily	 conserved	 protein	 so	
separation	 of	 cyt	 c	 from	 two	 different	 species	 could	 be	 seen	 as	 difficult	 to	 achieve.	
Clustering	was	also	seen	for	the	other	proteins,	but	these	clusters	are	all	located	within	the	
same	region.	The	use	of	3-D	LDA	was	then	explored,	in	the	hope	of	discriminating	between	
these	 clusters.	 The	 3-D	 LDA	 (Figure	 4.7b)	 again	 shows	 distinct	 clusters	 for	 the	 cyt	 c	
proteins,	 and	 clustering	 of	 the	 other	 proteins.	 However,	 the	 clustering	 of	 the	 other	
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As	all	 the	proteins	 could	not	be	discriminated	using	 just	 the	Ru(II)(bpy)3	 complexes	
the	use	of	a	second	 fluorophore	 to	produce	better	discrimination	was	 investigated.	With	















fluorophores	 by	 using	 different	 luminescent	 molecules	 already	 synthesised	 within	 the	
Wilson	 group.	 To	 this	 end	 the	 Ru(II)(bpy)3	complexes	 described	 previously	 and	 a	 FITC-
NOXA	 B	 peptide	 (sequence	 FITC-(Ga)AAQLARIGDKVNLRQKLLN-NH2),	 which	 had	 been	
synthesised	 by	 Dr.	 Katherine	 Horner,	 were	 used.	 Fluorescein	 is	 a	 logical	 fluorophore	
choice	 in	 this	 case;	 although	 its	maximum	excitation	wavelength	494	nm,	 is	higher	 than	
that	 used	 for	 the	Ru(II)(bpy)3	 complexes	 (467	 nm),	 467	 nm	 is	 still	within	 its	 excitation	




Due	 to	 the	 differences	 in	 quantum	 yield	 of	 the	 Ru(II)(bpy)3	 complexes	 and	 the	
fluorescein	moiety,	appropriate	concentrations	of	 the	species	 to	be	ascertained,	which	 i)	
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2.5	 μM	 Ru(II)(bpy)3	 complex	 solution	 and	 10	 μM	 protein	 were	 the	 concentrations	
selected	 for	 further	 study	 as	 these	 concentrations	 worked	 well	 with	 the	 Ru(II)(bpy)3	
array,	 showing	 specific	 responses	 to	 different	 proteins,	 even	 if	 they	 could	 not	 be	
discriminated.	Therefore	it	was	only	necessary	to	decide	on	a	compatible	concentration	of	
the	FITC-NOXA	B	peptide.	The	fluorescence	of	various	concentrations	of	the	FITC-peptide	
with	2.5	μM	of	Ru(II)(bpy)3	 complexes	29	was	 characterised	 (Figure	 4.9).	 From	 this,	 it	





RNAse	 A,	 papain,	 α-ChT	 and	 lysozyme)	 was	 performed,	 and	 the	 luminescence	 of	 the	











Generally	 the	 luminescence	 intensities	 of	 the	 different	 Ru(II)(bpy)3	 complexes	 was	
quenched	 (by	variable	amounts)	on	addition	of	 	 the	various	different	proteins,	 as	 in	 the	
Ru(II)(bpy)3	 complex-protein	 array	 discussed	 earlier.	 In	 the	 majority	 of	 cases	 the	
fluorescence	 intensity	 of	 the	 FITC-NOXA	 B	 peptide	 was	 enhanced.	 This	 is	 as	 would	 be	
expected	 for	 any	 binding	 to	 a	 protein	 surface	 as	 fluorescein	 is	 a	 solvatochromic	
fluorophore,	 changing	 its	 fluorescence	dependent	on	 the	 solvent	 (or	 local	 environment).		
Differences	 in	 its	 spectral	 properties	 dependent	 on	 polarity,194	 the	 state	 of	 hydrogen	











Another	 factor	which	was	 identified	as	 important	 for	 this	array	was	 incubation	time.	
Data	was	collected	after	2	hour	and	20	hour	incubations	(Figure	4.11a,	c	and	e	and	b,	d	
and	 f	 respectively)	 of	 the	 same	 plate,	 with	 subtlety	 different	 responses	 obtained	 after	
these	 two	 different	 incubations.	 The	 data	 obtained	 after	 both	 these	 incubations	 was	
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reproducible,	 indicating	 that	 after	 both	 these	 incubations,	 the	 system	 was	 indeed	 at	
equilibrium,	 however	 there	 was	 a	 different	 equilibrium	 present	 at	 these	 times.	 These	
differences	 might	 be	 expected	 for	 the	 two	 proteases	 used	 in	 the	 arrays	 (α-ChT	 and	
papain),	as	these	can	potentially	degrade	both	themselves	and	the	FITC-NOXA	B	peptide	at	
different	rates,	however	differences	are	observable	for	all	the	proteins,	this	shows	that	the	
system	is	more	complicated.	For	example,	 it	could	be	 that	 incubation	 for	 long	periods	of	
time	with	 the	Ru(II)(bpy)3	 complexes	 and	 the	 FITC-NOXA	B	 leads	 to	 changes	 in	 protein	






The	 data	 from	 these	 arrays	 were	 analysed	 using	 LDA.	 In	 two	 dimensions	 (Figure	
4.12),	 looking	at	the	2	discriminants	which	define	the	most	between	class	variation,	 it	 is	
seen	 that	all	 the	proteins	are	within	distinct	clusters,	 for	 the	2	hour	 incubation,	20	hour	
incubation	 and	 the	 combined	 data.	 In	 all	 three	 cases	 the	 data	 for	 the	 different	 proteins	
cluster	together,	with	the	cyt	c	always	being	in	a	distinct	separate	cluster.	After	2	hours	the	






















It	 is	 possible	 to	 plot	 confidence	 ellipsoids	 (Figure	 4.14),	 to	 see	 the	 confidence	 of	
discrimination	between	the	different	proteins.	For	this	6	protein	array	it	is	seen	that	at	the	
95	%	 confidence	 level	 (Figure	 4.14a)	 the	 ellipsoids	 are	 clearly	 distinct	 but	 have	 some	
overlap,	 this	 means	 that	 at	 the	 95	 %	 confidence	 level	 the	 proteins	 are	 not	 completely	
distinguished	from	each	other.	However,	at	the	80	%	confidence	level	(Figure	4.14b),	the	






Having	 had	 success	 in	 discriminating	 commercially	 available	 proteins,	 more	













From	 all	 the	 LDA	 performed,	 cyt	 c	 was	 always	 well	 separated	 from	 all	 the	 other	
proteins;	this	could	mean	that	the	separation	of	cyt	c	from	all	the	other	data	dominates	in	
the	 LDA,	 therefore	 it	 was	 hypothesised	 that	 it	 might	 be	 possible	 to	 separate	 the	 other	
proteins	 if	 cyt	c	was	 removed	 from	 the	analysis.	Upon	 removing	 the	 cyt	c	 data	 from	 the	




Looking	at	 the	80	%	and	95	%	confidence	ellipsoids	(Figure	 4.17)	 for	 these	data	shows	
ellipsoids	 for	 Mcl-1	 and	 hDM2	 distinct	 from	 the	 other	 proteins,	 but	 overlapping	 each	
other.	The	ellipsoids	 for	both	of	 these	proteins	 are	quite	 large	as	many	 fewer	 replicates	
were	performed	with	these	data	compared	to	with	the	other	proteins	(7	replicates	for	Mcl-
1	and	9	 for	hDM2,	 compared	 to	~30	 for	 the	other	proteins).	More	 replicates	 for	both	of	
these	 proteins	 may	 distinguish	 these	 two	 proteins	 more	 readily.	 The	 other	 protein	
confidence	ellipsoids	are	much	smaller	but	show	some	overlap	at	both	the	80	%	and	95	%	
confidence	 levels,	showing	that	while	 the	clusters	are	distinct	 from	each	other,	complete	
discrimination	 of	 the	 proteins	 is	 not	 achieved.	 However	 the	 small	 amounts	 of	 overlap	
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not	 be	 discriminated	 from	 each	 other,	 even	 in	 3-D.	 To	 increase	 the	 potential	 for	
discrimination	 the	 arrays	 were	 incubated	 with	 a	 second	 fluorophore,	 a	 FITC-NOXA	 B	
peptide.	 This	 generated	 a	 more	 complicated	 fingerprint	 response	 and	 allowed	 for	 the	











This	 thesis	 has	 focussed	 on	 the	 development	 of	 multivalent	 scaffolds	 (namely	
Ru(II)(bpy)3	 complexes	 and	 tetraphenyl-porphyrins)	 for	 their	 use	 as	 protein	 surface	
mimetics.	 The	 focus	 has	 centred	 on	 understanding	 how	 they	 interact	 with	 proteins,	
designing	new	platforms	for	the	development	of	high	affinity	 ligands	and	using	them	for	
new	applications	in	protein	detection	and	discrimination.	
In	 Chapter	 2,	 the	 utility	 of	 the	 Ru(II)(bpy)3	 scaffold	 to	 effectively	 mimic	 a	 native	
protein-protein	 interaction	(PPI)	was	 	established.	One	Ru(II)(bpy)3	complex	was	shown	
to	effectively	mimic	the	cytochrome	(cyt)	c/cyt	c	peroxidase	PPI,	binding	to	cyt	c	with	the	




enhance	 the	 interactions	 of	 a	 native	PPI	 using	 synthetic	molecules,	 in	 order	 to	 generate	
high	affinity	ligands	for	protein	surfaces.	Using	this	knowledge	the	rational	design	of	new	
protein	 surface	mimetics,	 based	on	both	 the	Ru(II)(bpy)3	 scaffold	 and	other	multivalent	
scaffolds	 for	 binding	 to	 new,	 more	 therapeutically	 interesting	 protein	 targets	 could	 be	








not	prove	 fruitful	 as	 the	protein	 could	not	be	 separated	 from	 the	 (quenched)	porphyrin	
dynamic	 combinatorial	 library,	 therefore	 a	method	 for	 separation	 of	 the	 porphyrin	DCL	
and	 protein	 needs	 to	 be	 established.	 This	 will	 firstly	 show	 if	 it	 is	 indeed	 possible	 to	
generate	 ligands	 for	 the	model	 protein	 cyt	 c,	 and	 then	 allow	 the	 incubation	with	 other,	
harder	to	target,	proteins	to	see	if	it	is	possible	to	generate	high	affinity	ligands	for	other	
protein	surfaces.		
In	 Chapter	 4,	 an	 array	 approach	 for	 the	 discrimination	 of	 different	 proteins	 by	
incubation	with	 two	 fluorophores	 (Ru(II)(bpy)3	 complexes	 and	 a	 FITC-labelled	 NOXA	 B	
	 102	
peptide)	 was	 presented.	 This	 allowed	 the	 discrimination	 of	 a	 range	 of	 different	
commercially	 available	 proteins,	 and	 showed	 some	 discrimination	 with	 the	 more	
therapeutically	 interesting	 proteins,	 Mcl-1	 and	 hDM2.	 This	 array	 could	 be	 expanded	 to	
include	 additional	 therapeutically	 interesting	 proteins,	 to	 see	 if	 it	 is	 possible	 to	
discriminate	a	range	of	proteins	of	 therapeutic	 interest.	The	use	of	 further	FITC	 labelled	
peptides,	or	the	addition	of	a	third	fluorophore	may	aid	in	this,	and	lead	to	a	tool	for	quick	
discrimination	and	later	identification	of	a	wide	range	of	proteins.		
Another	potential	platform	 for	 the	discrimination	of	different	proteins	 is	 to	 combine	
the	ideas	presented	in	Chapter	3	and	4,	using	the	composition	of	a	dynamic	combinatorial	
library	 generated	 in	 the	 presence	 of	 different	 proteins,	 to	 discriminate	 between	 the	
proteins.	Initial	experiments	in	this	vain	are	presented	in	Appendix	IV,	using	a	hydrazide	
functionalised	 Ru(II)(bpy)3	 complex	 in	 the	 presence	 of	 a	 range	 of	 aldehydes	 to	
discriminate	 between	 three	 different	 proteins.	 This	 approach	 requires	 more	 repeats	 to	





as	 PPI	 stabilisers.	 Initial	 results	 (presented	 in	 Appendix	 V)	 suggest	 that	 two	 of	 the	
synthesised	 Ru(II)(bpy)3	 	 complexes	 can	 stabilise	 the	 quaternary	 structure	 of	 a	mutant	
variant	(R337H)	of	the	p53	tetramerisation	domain.	Further	work	on	this	showing	that	the	
p53	tetramerisation	domain	is	 indeed	stabilised,	 for	example	by	proteolysis	experiments	


















or	 DRX500	 (500	MHz)	 spectrometers	 and	 referenced	 to	 either	 residual	 non-deuterated	
solvent	peaks	or	 tetramethylsilane.	 13C	 spectra	were	 recorded	on	a	Bruker	DPX	300	 (75	
MHz)	Bruker	or	an	Avance	500	(126	MHz)	and	referenced	to	the	solvent	peak.	1H	spectra	
are	 reported	 as	 follows:	 1H	 NMR	 (spectrometer	 frequency,	 solvent)	 δ	 ppm	 to	 2	 d.p.	
(multiplicity,	 J	 coupling	 constant	 in	 Hertz,	 number	 of	 protons,	 assignments).	 Chemical	
shifts	 (δ)	 are	 quoted	 in	 ppm	 with	 signal	 splitting	 recorded	 as	 singlet	 (s),	 doublet	 (d),	
triplet	(t),	quartet	(q),	quintet	(qu.)	multiplet	(m)	and	broad	(br.).	Coupling	constants	(J)	
are	 measured	 to	 the	 nearest	 0.1	 Hz.	 Similarly,	 13C	 spectra	 are	 reported	 as	 follows:	 δ	
(spectrometer	 frequency,	 solvent)	 δ	 ppm	 to	 one	 decimal	 place.	 Assignments	 of	 spectra	
were	 assisted	 by	 the	 results	 of	 DEPT,	 COSY,	 HMQC	 and	 HMBC	 experiments.	 13C	 NMR	
spectra	 were	 obtained	 for	 all	 novel,	 and	 most	 literature,	 small	 molecules	 and	 ligands.	
Where	possible	 13C	 spectra	were	 obtained	 for	 porphyrin	molecules,	 however	due	 to	 the	
large	molecular	size	and	thus	broadness	of	peaks	in	the	1H	NMR,	13C	NMR	spectra	were	not	




Infrared	 spectra	 were	 recorded	 on	 a	 Perkin	 Elmer	 Fourier-Transfer	 spectrometer.	








Potassium	 dichromate	 (9.10	 g,	 30.9	 mmol)	 was	 added	 to	 a	 stirred	 solution	 of	 4,4’-
dimethyl-2,2’-bipyridine,		39	(2.00	g,	10.9	mmol)	in	concentrated	sulfuric	acid	(50	mL)	at	
70°C	over	2	hours,	keeping	the	temperature	between	70	and	80	°C.	After	the	addition,	the	
hot	 solution	 was	 poured	 onto	 ice	 (200	 g)	 and	 the	 ice	 allowed	 to	 melt.	 The	 off-white	
precipitate	 formed	was	 isolated	by	vacuum	filtration.	The	solid	was	redissolved	 in	50	%	
nitric	acid	(50	mL)	and	the	solution	heated	under	reflux	for	2	hours.	The	resulting	mixture	
was	 cooled	 and	 poured	 onto	 ice	 (200	 g)	 and	 the	 white	 precipitate	 isolated	 by	 vacuum	







4,4’-dicarboxylic	 acid,	40	 (3.00	g,	 12.3	mmol)	 in	 anhydrous	methanol	 (200	mL)	under	 a	
nitrogen	 atmosphere	 and	 the	 resulting	 solution	 heated	 under	 reflux	 for	 20	 hours.	 The	


























Ru(III)Cl3.xH2O	(1.00	g)	 in	anhydrous	dimethylsulfoxide	 (5	mL)	was	degassed	 for	30	
minutes.	The	solution	was	then	heated	under	reflux	under	a	nitrogen	atmosphere	for	30	
minutes.	 Half	 of	 the	 solvent	 was	 then	 boiled	 off	 and	 the	 mixture	 cooled	 to	 room	
temperature.	The	reaction	mixture	was	then	diluted	with	acetone	(10	mL)	and	the	yellow	
precipitate	isolated.	To	yield	the	product	as	a	yellow	solid	(1.89	g,	3.91	mmol);	ESI-MS	m/z	
found	 501.9317	 [M+NH4]+,	 [C8H28NO4S4Ru]+	 requires	 501.9322.	 (Poor	 solubility	 of	 this	
compound	in	all	but	DMSO	meant	NMR	spectra	could	not	be	obtained)	
Tris	 (4,4’-dimethylester-2,2’-bipyridine)	 ruthenium(II)	 dihexafluorophosphate,	
49142	
	





























Tris	 (4,4’-dimethylester-2,2’-bipyridine)	 ruthenium(II)	 dihexafluorophosphate,	 49	
(1.00	g,	0.828	mmol)	in	ethanol		(20	mL)	and	1	M	sodium	hydroxide	solution	(20	mL)	was	




(solid	 state,	 cm-1)	 3305	 (O-H),	 1600	 (C=O	 acid);	 ESI-MS	 m/z	 found	 417.0246	 [M]2+,	
[C36H24N6O12Ru]2+	requires	417.0248	
Ethyl	 2-[(2-{4-	 [(2-ethoxy-2-oxoethyl)	 carbamoyl]	 pyridin-2-yl}	 pyridin-4-yl)	
formamido]	acetate,	41f	
	
2,2’-Bipyridine-4,4’-carboxylic	 acid,	40	 (1.50	 g,	 6.14	mmol)	 and	 thionyl	 chloride	 (20	
mL)	were	heated	under	reflux	 for	16	hours,	 the	solvent	was	then	removed	 in	vacuo,	and	
the	 dry	 acid	 chloride	 flushed	 with	 nitrogen	 and	 used	 immediately.	 	 To	 the	 dry	 acid	
chloride	was	added	anhydrous	chloroform	(40	mL),	ethyl	glycine	hydrochloride	salt	(1.89	
g,	 13.5	mmol)	 and	 triethylamine	 (1.88	mL,	13.5	mmol)	 and	 the	 reaction	mixture	heated	
under	 reflux,	 under	 a	 nitrogen	 atmosphere,	 for	 16	 hours.	 The	 reaction	was	 then	 cooled	
and	concentrated	 to	yield	 the	crude	product	as	a	pink	solid,	which	was	purified	by	 flash	












































mmol)	 in	 thionyl	 chloride	 (10	mL)	 and	 dimethylformamide	 (1	 drop)	was	 heated	 under	
reflux	for	18	hours.	The	reaction	mixture	was	then	concentrated	in	vacuo	and	flushed	with	
nitrogen	 to	 yield	 the	 acid	 chloride	 as	 a	 red	 solid.	 The	 acid	 chloride	was	 resuspended	 in	
anhydrous	chloroform	(30	mL)	and	ethyl	glycine	hydrochloride	salt	 (94	mg,	0.50	mmol)	
and	diisopropylethylamine	 (0.17	mL,	0.99	mmol)	were	added.	The	reaction	mixture	was	
heated	 under	 reflux	 for	 18	 hours.	 The	 reaction	 mixture	 was	 then	 cooled	 to	 room	
temperature	and	washed	with	saturated	sodium	hydrogen	carbonate	solution	(30	mL),	1	

























(N-H),	 1734	 (C=O	 ester),	 1664	 (C=O	 amide);	 ESI-MS	 m/z	 found	 672.1840	 [M]2+,	
[C60H66N12O18Ru]2+	requires	672.1834	
Tris	 (2-	 [(2-	 {4-[(carboxymethyl)	 carbamoyl]	 pyridin-2-yl}	 pyridin-4-yl)	
formamido]acetic	acid)	ruthenium(II)	dichloride,	30	
	


















































2,2’-Bipyridine-4,4’-dicarboxylic	 acid,	 40	 (100	 mg,	 0.400	 mmol),	 triethylamine	 (1	
drop)	and	 thionyl	 chloride	 (10	mL)	were	heated	under	 reflux	 for	16	hours.	The	mixture	
was	 cooled	 to	 room	 temperature	 and	 the	 solvent	 removed	 in	 vacuo	 to	 yield	 the	 acid	
chloride	as	an	orange-red	solid.		The	dry	acid	chloride	was	then	redissolved	in	anhydrous	
chloroform	 (20	mL)	 and	 added	dropwise	 to	 a	 stirred	 solution	of	 di-tert	 butyl	 L-aspartic	
acid.hydrogen	chloride	salt	(253	mg,	0.901	mmol)	and	triethylamine	(0.25	mL,	1.80	mmol)	
in	anhydrous	chloroform	at	0	°C,	under	a	nitrogen	atmosphere.	The	reaction	mixture	was	
warmed	 to	 room	 temperature	 and	 heated	 under	 reflux	 for	 48	 hours.	 The	 mixture	 was	
cooled	 to	 room	 temperature	 and	 the	 solvent	 removed	 to	 yield	 the	 crude	 product	 as	 a	






142.3,	 150.1,	 156.3,	 165.1,	 169.5,	 170.2;	 IR	 (solid	 state,	 cm-1)	 3346	 (N-H),	 1723	 (C=O	
ester),	1650	(C=O	amide);	ESI-HRMS:	found	m/z	699.3615	[M+H]+,	[C36H51N4O10]+	requires	
699.3599	




disuccinate,	 41g	 (300	 mg,	 0.429	 mmol),	 Ru(II)(DMSO)4Cl2	 (65	 mg,	 0.134	 mmol),	 silver	
nitrate	 (46	mg,	 0.268	mmol)	 and	 ethanol	 (20	mL)	were	 heated	under	 reflux	 for	 7	 days.	
After	which	time	the	reaction	mixture	was	filtered	hot	and	concentrated.	The	red	solid	was	
then	dissolved	in	a	minimum	amount	of	ethanol	and	loaded	onto	an	SP	Sephadex	column	
and	 eluted	 with	 1:1	 acetone:	 0.1	 M	 sodium	 chloride	 solution	 and	 all	 the	 red	 fractions	
collected	and	concentrated.	The	combined	red	fractions	were	redissolved	in	acetone	and	
filtered	 to	 remove	 sodium	chloride,	 and	 this	was	 repeated	until	 no	more	white	 salt	was	



























































































a	 nitrogen	 atmosphere,	 for	 16	 hours.	 The	 resulting	 solution	was	 then	washed	with	 1	M	
hydrochloric	 acid	 (50	mL),	 saturated	 sodium	 hydrogen	 carbonate	solution	 (50	mL)	 and	
brine	(50	mL).	The	organic	phase	was	dried	(sodium	sulfate)	and	concentrated	to	yield	the	












(1.00	 g,	 1.65	mmol)	was	dissolved	 in	methanol	 (20	mL)	 and	 ethyl	 acetate	 (20	mL).	 The	
reaction	mixture	was	degassed	and	palladium	on	activated	 charcoal	 (11	mg)	was	added	
and	the	solution	degassed	again.	The	solution	was	then	put	under	a	hydrogen	atmosphere	
and	stirred	 for	16	hours.	The	 solution	was	 then	 filtered	 twice	and	concentrated	 to	yield	





























carbamoyl}	 -5-	 [2-	 (4-	 {[3,5-bis	 ({[(2S)-1,4-bis	 (tert-butoxy)-1,4-	 dioxobutan-2-yl]	
carbamoyl})	 phenyl]	 carbamoyl}	 pyridin-2-yl)	 pyridine-4-amido]	 phenyl)	
formamido]butanedioate,	41b	
	
2,2’-Bipyridine-4,4’-dicarboxylic	 acid,	 40	 (128	 mg,	 0.524	 mmol)	 was	 heated	 under	
reflux	 in	 thionyl	 chloride	 (10	mL)	 for	 18	 hours,	 and	 the	 solvent	 removed	 in	 vacuo.	 The	
resultant	acid	chloride	was	flushed	with	nitrogen	and	used	immediately.	The	acid	chloride	
was	redissolved	in	anhydrous	chloroform	(15	mL)	and	heated	to	reflux,	under	a	nitrogen	
atmosphere.	 A	 solution	 of	 (2S,2'S)-tetra-tert-butyl	 2,2'-((5-aminoisophthaloyl)	
bis(azanediyl))	disuccinate	(600	mg,	0.943	mmol),	38b	and	anhydrous	triethylamine	(0.16	






















































carbamoyl}	 -5-[2-	 (4-	 {[3,5-bis	 ({[(2S)	 -1,4-	bis	 (tert-butoxy)	 -1,4-	 dioxobutan-2-yl]	
carbamoyl})	 phenyl]	 carbamoyl}	 pyridin-2-yl)	 pyridine-4-amido]phenyl)	
formamido]	butanedioate)	ruthenium(II)	dinitrate,	42b	
	




0.540	mmol)	 in	 ethanol	 (30	mL)	were	heated	under	 reflux	 for	6	days.	The	 solution	was	










































































chloride	 (20	 mL)	 were	 heated	 under	 reflux	 for	 18	 hours.	 The	 solvent	 was	 removed	 in	
vacuo	 to	 yield	 the	 acid	 chloride	 as	 a	 white	 solid.	 The	 acid	 chloride	 was	 redissolved	 in	
anhydrous	dichloromethane	(40	mL),	dimethyl	L-aspartic	acid	hydrochloride	salt	(4.12	g,	
20.8	mmol)	and	triethylamine	(2.92	mL,	20.8	mmol)	were	added	and	the	reaction	mixture	
stirred	 for	 16	 hours.	 The	 resulting	 solution	 was	 quenched	 with	 saturated	 sodium	
hydrogen	 carbonate	 solution	 (50	 mL).	 The	 organic	 phase	 was	 then	 washed	 with	 1	 M	
hydrochloric	acid	(50	mL)	and	brine	(50	mL),	dried	(sodium	sulfate)	and	concentrated	to	
yield	the	crude	product	as	a	beige	solid,	this	was	purified	by	flash	column	chromatography	











































1,4-Dimethyl	 (2S)-2-({3-[2-(4-{[3,5-	bis	 ({[(2S)-1,4-	 dimethoxy-1,4-	 dioxobutan-




mL)	was	heated	under	 reflux	 for	18	hours.	The	solvent	was	 then	removed	 in	vacuo,	 and	
the	resulting	acid	chloride	flushed	with	nitrogen	and	used	immediately.	The	acid	chloride	
was	redissolved	in	anhydrous	chloroform	(10	mL)	and	heated	to	reflux,	under	a	nitrogen	
atmosphere.	 A	 solution	 of	 1,4-dimethyl	 (2S)-2-[(3-amino-5-{[(2S)-1,4-dimethoxy-1,4-
dioxobutan-2-yl]carbamoyl}phenyl)formamido]butanedioate,	 38a	 (1.62	 g,	 3.47	 mmol)	
and	anhydrous	triethylamine	(0.59	mL,	4.3	mmol)	in	anhydrous	chloroform	(20	mL),	kept	
under	 a	 nitrogen	 atmosphere	 was	 added	 dropwise	 to	 the	 refluxing	 solution	 and	 the	
solution	 then	heated	under	 reflux	 for	16	hours.	 	The	 reaction	mixture	was	concentrated	







150.3,	 155.6,	 164.1,	 165.8,	 170.5,	 171.1;	 IR	 (solid	 state,	 cm-1)	 3306	 (N-H),	 3011	 (N-H),	













































Tris	 (1,4-	 dimethyl	 (2S)-2-({3-[2-(4-{[3,5-bis({[(2S)-1,4-dimethoxy-1,4-
dioxobutan-2-yl]carbamoyl})	 phenyl]	 carbamoyl}	 pyridin-2-yl)	 pyridine-4-amido]-
5-	 {[(2S)-1,4-dimethoxy-1,4-	 dioxobutan-2-yl]	 carbamoyl}	 phenyl}	 formamido)	
butanedioate)	ruthenium(II)	dinitrate,	42b142	
	
1,4-Dimethyl	 (2S)-2-	 ({3-[2-(4-{[3,5-bis	 ({[(2S)-1,4-dimethoxy	 -1,4-	 dioxobutan-2-yl]	
carbamoyl})	phenyl]	carbamoyl}	pyridin-2-yl)	pyridine-4-amido]-5-{[(2S)-1,4-dimethoxy-
1,4-dioxobutan-2-yl]carbamoyl}phenyl}formamido)butanedioate,	 41a	 (1.00	 g,	 0.875	
mmol),	Ru(II)(DMSO)4Cl2	(132	mg,	0.273	mmol)	and	silver	nitrate	(93	mg,	0.547	mmol)	in	
ethanol	 (20	 mL)	 were	 heated	 under	 reflux	 for	 7	 days.	 The	 reaction	 mixture	 was	 then	
filtered	and	the	red	filtrate	concentrated	to	yield	the	crude	product	as	a	red	solid.	This	was	






























































-1,4-dioxobutan-2-yl]	 carbamoyl}	 phenyl}	 formamido)	 butanedioate)	 ruthenium(II)	







(N-H),	 2549	 (O-H	 acid),	 1625	 (C=O	 acid),	 1601	 (C=O	 amide);	 ESI-HRMS	 found	 m/z	
1596.211	[M]2+,	[C132H114N24O66Ru]2+	requires	1596.2672	




oxoethyl)formamido)acetate,	 37b	 (synthesised	 by	 Georgina	 Pleasance,	 974	 mg,	 1.76	






























































ppm	14.1,	 14.2,	 47.4,	 51.6,	 61.4,	 61.7,	 113.8,	 114.5,	 136.4,	 147.5,	 168.8,	 169.0,	 171.5;	 IR	









redissolved	 in	 anhydrous	 chloroform	 (10	 mL)	 and	 heated	 to	 reflux	 under	 a	 nitrogen	
atmosphere.	 	 A	 solution	 of	 ethyl	 2-(1-{3-amino-5-[bis(2-ethoxy-2-oxoethyl)	 carbamoyl]	
phenyl}	 -N-	 (2-ethoxy-2-oxoethyl)	 formamido)	 acetate,	 38c	 (702	 mg,	 1.34	 mmol)	 and	
anhydrous	 triethylamine	 (0.23	 mL,	 1.63	 mmol)	 in	 anhydrous	 chloroform	 (15	 mL)	 was	
added	dropwise	 to	 the	 refluxing	 solution	and	 the	 resulting	 solution	heated	under	 reflux	


















































mmol)	 and	 triethylamine	 (0.44	mL,	 3.1	mmol)	 added	 and	 the	 resulting	mixture	 stirred,	
under	a	nitrogen	atmosphere,	for	18	hours.	The	reaction	mixture	was	then	concentrated	to	










methanone),	 37d	 (650	 mg,	 0.926	 mmol)	 was	 dissolved	 in	 methanol	 (10	 mL)	 and	 the	





























































nitrogen	 atmosphere.	 The	 solution	 was	 then	 heated	 under	 reflux	 for	 48	 hours.	 The	
reaction	mixture	was	concentrated	to	yield	the	crude	product	as	a	red-brown	solid,	which	























































Tris	 (N4,N4’-bis	 (3,5-di	 (1,4,7,10,13-pentaoxa-16-azacyclooctadecane-16-






under	 reflux	 for	 7	 days.	 The	 resulting	 red	 solution	 was	 then	 filtered	 and	 the	 filtrate	
concentrated	 in	 vacuo.	 The	 resulting	 red	 solid	 was	 purified	 by	 flash	 alumina	 column	
chromatography	(1	–	10	%	methanol	in	chloroform)	and	the	red	fractions	collected.	These	




18	 H,	 H5	 +	 H2),	 8.06	 -	 8.13	 (m,	 6	 H,	 H1);	 IR	 (solid	 state,	 cm-1)	 3423	 (N-H),	 1672	 (C=O	
amide),	 1627	 (C=O	 amide)	 (MS	 was	 not	 able	 to	 be	 obtained,	 presumably	 due	 to	 the	
multiple	ionisation	states	present	due	to	chelation	of	many	different	ions)	





































































removed	 in	 vacuo	 to	 yield	 the	 acid	 chloride	 as	 a	 pale	 yellow	 solid,	 which	 was	 reacted	
immediately.	 The	 acid	 chloride	was	 redissolved	 in	 anhydrous	 dichloromethane	 (15	mL)	
and	 N-boc-1,6-diaminohexane	 (0.47	 mL,	 2.09	 mmol)	 and	 triethylamine	 (0.29	 mL,	 2.09	
mmol)	added	and	the	resulting	solution	strired	for	18	hours.	After	which	time	the	mixture	
was	washed	with	1	M	hydrochloric	acid	 (50	mL),	 saturated	 sodium	hydrogen	carbonate	
solution	 (50	 mL)	 and	 brine	 (50	 mL),	 and	 dried	 (sodium	 sulfate).	 The	 solution	 was	
concentrated	to	yield	the	crude	product	as	a	yellow	oil.	The	crude	product	was	purified	by	




H1),	8.89	 (s,	 2	H,	H2);	 13C	NMR	 (75	MHz,	CDCl3)	δ	ppm	25.6,	25.9	28.4,	29.1,	29.9,	39.9,	
79.2,	124.8,	131.0,	136.6,	148.4,	156.6,	164.6;	IR	(solid	state,	cm-1)	3342	(N-H),	1674	(C=O	
carbamate),	 1645	 (C=O	 amide),	 1580	 (NO2),	 1517	 (NO2);	 ESI-MS	m/z	 found	 	 608.3672	
[M+H]+,	[C30H50N5O8]+	requires	608.3659	





palladium	 on	 activated	 charcoal	 added	 (156	 mg)	 and	 the	 solution	 degassed	 again.	 The	
reaction	mixture	was	then	placed	under	a	hydrogen	atmosphere	and	stirred	for	18	hours.	

























Tert-butyl	 N-{6-[(3-{2-[4-({3,5-bis[(6-{[(tert-butoxy)	 carbonyl]	 amino}	 hexyl)	




2,2’-Bipyridine-4,4’-dicarboxylic	 acid,	40	 (100	mg,	0.410	mmol)	 and	 thionyl	 chloride	
(10	mL)	were	heated	under	reflux	for	18	hours.	The	reaction	mixture	was	concentrated	in	
vacuo	 and	 the	 acid	 chloride	 flushed	 with	 nitrogen	 and	 reacted	 immediately.	 The	 acid	
chloride	was	redissolved	in	anhydrous	chloroform	(10	mL)	and	heated	to	reflux,	under	a	
nitrogen	 atmosphere.	 A	 solution	 of	 di-tert-butyl(((5-aminoisophthaloyl)bis(azanediyl))	
bis(hexane-6,1-diyl))dicarbamate,	 38e	 (426	 mg,	 0.737	 mmol)	 and	 anhydrous	
triethylamine	 (0.13	mL,	0.90	mmol)	 in	 anhydrous	 chloroform	 (25	mL)	under	a	nitrogen	
atmosphere	 was	 added	 dropwise	 to	 the	 refluxing	 solution	 and	 the	 resulting	 mixture	
heated	under	reflux	for	18	hours.	The	reaction	mixture	was	then	concentrated	to	yield	the	
crude	product	as	a	pink	solid,	which	was	purified	by	flash	column	chromatography	(5	–	20	














































carbamoyl]	 phenyl}	 carbamoyl)	 pyridin-2-yl]	 pyridine-4-amido}-5-	 [(6-
{[(tertbutoxy)	 carbonyl]	 amino}	 hexyl)	 carbamoyl]	 phenyl)	 formamido]	 hexyl}	
carbamate))		ruthenium(II)	dinitrate,	42e142,143	
	
Tert-butyl	 N-	 {6-	 [(3-	 {2-	 [4-({3,5-bis	 [(6-	 {[(tert-	 butoxy)	 carbonyl]	 amino}	 hexyl)	
carbamoyl]	 phenyl}	 carbamoyl)	 pyridin-	 2-	 yl]	 pyridine-4-	 amido}	 -5-[(6-	 {[(tert-
butoxy)carbonyl]amino}hexyl)carbamoyl]phenyl)formamido]hexyl}carbamate,	 41e	 (172	
mg,	 0.126	 mmol),	 Ru(II)(DMSO)4Cl2	 (19	 mg,	 0.0394	 mmol)	 and	 silver	 nitrate	 (13	 mg,	
0.0788	 mmol)	 in	 ethanol	 (20	 mL)	 were	 heated	 under	 reflux	 for	 7	 days.	 The	 reaction	


















































Tris	 (N1,N3-bis	 (6-aminohexyl)-5-{2-[4-({3,5-bis	 [(6-aminohexyl)	 carbamoyl]	
phenyl}	 carbamoyl)	 pyridin-2-yl]	 pyridine-4-amido}	 benzene-1,3-dicarboxamide)	
ruthenium(II)	dichloride,	35142,143	
	
Tris	 (tert-butyl	 N-{6-[(3-{2-[4-({3,5-bis[(6-{[(tert-butoxy)carbonyl]	 amino}	 hexyl)	
carbamoyl]	 phenyl}	 carbamoyl)	 pyridin-2-yl]	 pyridine-4-	 amido}-5-[(6-{[(tertbutoxy)	
carbonyl]amino}hexyl)carbamoyl]phenyl)formamido]hexyl}carbamate))	 ruthenium(II)	
dinitrate,	 42e	 (50	 mg,	 0.012	mmol)	 in	 1	 M	 hydrogen	 chloride	 in	 dioxane	 	 (5	 mL)	 was	









































































[C36H36N18O6Ru]2+	 requires	 459.1054	 (this	 Ru(II)(bpy)3	 complex	 is	 not	 stable	 to	 O2	 and	
was	therefore	reacted	on	immediately)	
Tris	 (N'-	 [(1E)-	 phenylmethylidene]	 -2-(4-{N'-	 [(1E)-	 phenylmethylidene]	
hydrazinecarbonyl}	 pyridin-2-yl)	 pyridine-4-carbohydrazide)	 ruthenium(II)	
dihexafluorophosphate,	46a	
	
To	 tris	 ([2,2'-bipyridine]-4,4'-dicarbohydrazide)	 ruthenium(II)	 dihexafluoro-
phosphate,	43	(94	mg,	0.0778	mmol)	in	degassed	acetonitrile	(10	mL)	and	water	(10	mL)	








































amide),	 1654	 (C=N);	 ESI-MS	 m/z	 found	 723.2003	 [M]2+,	 [C78H60N18O6Ru]2+	 requires	
723.1993	
Tris	 (N'-	 [(1E)-	 (2,4-	 dimethoxyphenyl)	 methylidene]	 -2-	 (4-{N'-	 [(1E)-	 (2,4-
dimethoxyphenyl)	 methylidene]	 hydrazinecarbonyl}	 pyridin-2-yl)	 pyridine-4-
carbohydrazide)		dihexafluorophosphate,	46b	
	
To	 tris	 ([2,2'-bipyridine]-4,4'-dicarbohydrazide)	 ruthenium(II)	 dihexafluoro-
phosphate,	43	(94	mg,	0.0778	mmol)	in	degassed	acetonitrile	(10	mL)	and	water	(10	mL)	
under	 a	 nitrogen	 atmosphere	 was	 added	 2,4-dimethoxy	 benzaldehyde	 (148	 mg,	 0.891	
mmol)	 and	 stirred	 for	 16	 hours.	 The	 solution	 was	 then	 concentrated	 in	 vacuo,	 and	 the	
resulting	 red	 solid	 suspended	 in	 chloroform	 (20	 mL)	 and	 filtered.	 The	 precipitate	 was	
redissolved	in	acetonitrile	and	filtered,	the	filtrate	was	concentrated	to	yield	the	product	


































formamido]	 acetate)	 ruthenium(II)	 dinitrate,	42f	 (50	mg,	 0.0340	mmol)	 and	 hydrazine	
monohydrate	(0.02	mL,	0.408	mmol)	in	ethanol	(5	mL)	were	heated	under	reflux,	under	a	
nitrogen	 atmosphere,	 for	18	hours,	 then	 filtered.	The	 red	precipitate	was	 redissolved	 in	
water,	filtered	and	concentrated	to	yield	the	product	as	a	red	solid	(45	mg,	0.034	mmol,	95	
%);	1H	NMR	(500	MHz,	D2O)	δ	ppm	4.08	(s,	12	H,	H5),	7.73	(d,	J	=	5.4	Hz,	6	H,	H2),	7.94	(d,	J	
=	5.4	Hz,	6	H,	H3)	8.97	 (s,	6	H,	H1);	 IR	 (solid	 state,	 cm-1)	3246	 (N-H),	3065	 (N-H),	1733	






To	 tris	 (N-	 [(hydrazinecarbonyl)	 methyl]-2-	 (4-	 {[(hydrazinecarbonyl)	 methyl]	
carbamoyl}	 pyridin-2-yl)pyridine-4-carboxamide)	 ruthenium(II)	 dinitrate,	 49	 (50	 mg,	
0.036	 mmol)	 in	 degassed	 acetonitrile	 (10	 mL)	 and	 water	 (10	 mL)	 under	 a	 nitrogen	
atmosphere	was	 added	 benzaldehyde	 (148	mg,	 0.891	mmol)	 and	 the	 resulting	 solution	
stirred	for	30	minutes.	The	solution	was	then	concentrated	in	vacuo,	and	the	resulting	red	















































H2),	8.00	 -	8.14	(m,	8	H,	H8),	8.25	(br.	 s,	4	H,	H8’),	9.39	(br.	 s,	6	H,	H3),	9.50	(br.	 s,	4	H,	
H10),	9.70	(d,	J	=	23.8	Hz,	2	H,	H10’),	11.62	(br.	s,	4	H,	H7),	11.65	-	11.71	(m,	2	H,	H7’)	(cis	
and	 trans	hydrazone	 isomers	 observed	 in	 1:2	 ratio);	 IR	 (solid	 state,	 cm-1)	 3218	 (N-H),	
1655	 (C=O	 amide),	 1541	 (C=N);	 ESI-MS	 found	m/z	 894.2639	 [M]2+,	 	 [C90H78N24O12Ru]2+	
requires	894.2640	
Tris	 (N-({N'-[(1E)-2,4	 dimethoxy	 phenylmethylidene]	 hydrazinecarbonyl}	
methyl)-2-{4-[({N'-[(1E)-2,4	 dimethoxy	 phenylmethylidene]	 hydrazinecarbonyl}	
methyl)carbamoyl]	pyridin-2-yl}pyridine-4-carboxamide)		dinitrate,	50b	
	
To	 tris	 (N-[(hydrazine	 carbonyl)	 methyl]-2-(4-{[(hydrazine	 carbonyl)	 methyl]	
carbamoyl}pyridin-2-yl)pyridine-4-carboxamide)	 ruthenium(II)	 dinitrate	 (50	 mg,	 0.036	
mmol)	in	degassed	acetonitrile	(10	mL)	and	water	(10	mL)	under	a	nitrogen	atmosphere	
was	 added	 2,4-dimethoxy	 benzaldehyde	 (46	mg,	 0.43	mmol)	 and	 the	 resulting	 solution	
stirred	for	30	minutes.	The	solution	was	then	concentrated	in	vacuo,	and	the	resulting	red	







































Tris	 (N-({N'-[(1E)-4	 hydroxy	 phenylmethylidene]hydrazinecarbonyl}methyl)-2-
{4-[({N'-[(1E)-4	 hydroxy	 phenyl	 methylidene]	 hydrazine	 carbonyl}	 methyl)	
carbamoyl]	pyridin-2-yl}pyridine-4-carboxamide)		dinitrate,	50d		
	













oxopropan-2-yl]	 carbamoyl}	 pyridin-2-yl)	 pyridin-4-yl]formamido}	 propanoate)	
ruthenium(II)	dichloride,	41j	
	















































2.4	mmol)	were	 added	 to	 the	 refluxing	 solution	 and	 the	 reaction	mixture	 heated	 under	
reflux	 for	 18	 hours	 under	 a	 nitrogen	 atmosphere.	 The	 reaction	 mixture	 was	 cooled	 to	
room	 temperature	 and	washed	with	 saturated	 sodium	hydrogen	 carbonate	 solution	 (30	
mL),	 1	 M	 hydrochloric	 acid	 (30	 mL)	 and	 brine	 (30	 mL).	 The	 organic	 phase	 was	 dried	
(sodium	 sulfate)	 and	 concentrated	 to	 yield	 the	 crude	 product	 as	 a	 red	 solid.	 This	 was	












oxopropan-2-yl]	 carbamoyl}	 pyridin-2-yl)	 pyridin-4-yl]	 formamido}	 propanoate)	


























Tris	 (N4,	 N4'-	 bis	 (6-boc	 aminohexyl)	 -2,2'-	 bipyridine-	 4,4'-	 dicarboxamide)	
ruthenium(II)	dichloride,	41i	
	
Tris	 (2,2'-bipyridine-4,4'-dicarboxylic	 acid)	 ruthenium(II)	 dichloride,	 29	 (114	 mg,	
0.125	mmol)	was	heated	under	reflux	in	thionyl	chloride	(30	mL)	and	dimethylformamide	
(1	drop)	for	6	hours.	The	solvent	was	removed	in	vacuo	and	the	resulting	red	acid	chloride	















































in	 water	 (10	 mL).	 The	 solution	 was	 neutralised	 by	 addition	 of	 1	 M	 sodium	 hydroxide	





cm-1)	 3386	 (N-H),	 3255	 (N-H),	 1717	 (C=O	 amide);	 ESI-MS	m/z	 found	 711.3884	 [M]2+,	
[C72H108N18O6Ru]2+	requires	711.3871	
Tris	 (4-tert-butyl	 1-methyl	 (2S)-2-[(4'-{[(2S)-4-(tert-butoxy)-1-methoxy-1,4-
dioxobutan-2-yl]	 carbamoyl}-	 [2,2'-bipyridin]-4-yl)	 formamido]	 butanedioate)	
ruthenium(II)	dichloride,	41k	
	
Tris	 (2,2'-bipyridine-4,4'-dicarboxylic	 acid)	 ruthenium(II)	 dichloride	 (50	 mg,	 0.055	
mmol)	was	 heated	 under	 reflux	 in	 thionyl	 chloride	 (20	mL)	 and	 dimethylformamide	 (1	
drop)	 for	6	hours.	The	reaction	mixture	was	concentrated	 in	vacuo	and	the	acid	chloride	












































mixture	 heated	 under	 reflux	 under	 a	 nitrogen	 atmosphere	 for	 18	 hours.	 The	 resulting	
solution	 was	 then	 cooled	 to	 room	 temperature	 and	 washed	 with	 saturated	 sodium	
hydrogen	carbonate	solution	(50	mL),	1	M	hydrochloric	acid	(50	mL)	and	brine	(50	mL).	
The	organic	phase	was	dried	(sodium	sulfate)	and	concentrated	to	yield	the	crude	product	













mL)	 to	 yield	 the	 crude	 product	 as	 an	 off-white	 solid.	 This	was	 purified	 by	 flash	 column	
chromatography	(20	%	ethyl	acetate	in	dichloromethane)	to	yield	the	product	as	a	white	





46.6,	 54.2,	 61.4,	 61.8,	 65.8,	 72.9,	 120.0,	 127.0,	 127.6,	 125.4,	 140.7,	 143.7,	 143.8,	 155.0,	


























amount	 of	 ethyl	 acetate	 and	 precipitated	 with	 hexane.	 The	 suspension	 was	 filtered	
through	 a	 celite	 pad	 and	 washed	 with	 hexane.	 The	 celite	 pad	 was	 then	 washed	 with	




27.2,	 42.1,	 63.2,	 73.4,	 80.6,	 156.3.	 172.5;	 IR	 (solid	 state,	 cm-1)	 3368	 (N-H),	 3242	 (N-H),	
1720	 (C=O	 carbamate),	 1692	 (C=O	 amide);	 ESI-MS	 m/z	 found	 276.1923	 [M+H]+,	
[C12H26N3O4]+	requires	276.1923	
N4,N4'-	 bis	 [(1S)	 -2-	 (tert-	 butoxy)	 -1-	 {N'-	 [(tert-	 butoxy)	 carbonyl]	
hydrazinecarbonyl}	ethyl]-[2,2'-bipyridine]-4,4'-dicarboxamide,	68	
	
2,2’-Bipyridine-4,4’-dicarboxylic	 acid,	 40	 (241	 mg,	 0.988	 mmol)	 was	 heated	 under	
reflux	 in	 thionyl	 chloride	 (30	 mL)	 for	 18	 hours,	 and	 the	 reaction	 mixture	 then	
concentrated	 in	 vacuo.	 The	 resultant	 acid	 chloride	 was	 flushed	 with	 nitrogen	 and	 used	
immediately.	 The	 acid	 chloride	 was	 redissolved	 in	 anhydrous	 chloroform	 (30	 mL)	 and	
heated	 to	 reflux,	 under	 a	 nitrogen	 atmosphere.	 	 Tert-butyl	 2-(2-amino-3-tert-





























































65.7,	 79.7,	 120.1,	 125.3,	 127.1,	 127.6,	 140.7,	 143.8,	 155.1,	 155.8,	 171.0,	 171.6;	 IR	 (solid	


































oxobutanoyl)	 hydrazine	 carboxylate,	61b	 (1.85	 g,	 3.52	mmol)	 in	 20	%	 diethylamine	 in	
acetonitrile	(50	mL)	was	stirred	for	16	hours.	The	reaction	solution	was	then	concentrated	
and	 the	 resulting	 residue	 redissolved	 in	 a	 minimal	 amount	 of	 ethyl	 acetate,	 and	
precipitated	by	addition	of	hexane.	The	slurry	was	then	filtered	through	celite.	The	celite	
pad	was	then	washed	with	dichloromethane	and	methanol	and	this	 filtrate	concentrated	
to	yield	 the	product	 as	 an	off-white	waxy	 solid	 (1.03	g,	 3.40	mmol,	96%);	 1H	NMR	 (500	
MHz,	CDCl3)	δ	ppm	1.48	(s,	9	H,	H1/H2),	1.50	(s,	9	H,	H1/H2),	2.59	(dd,	J	=	16.7,	8.1	Hz,	1	H,	
H4),	2.82	(dd,	J	=	16.7,	3.7	Hz,	1	H,	H4’),	3.16	(br.	s,	1	H,	H3),	3.91	(br.	s,	2	H,	H6),	6.38	(br.	
s,	 1	 H,	 H2);	 13C	 NMR	 (101	MHz,	 MeOD)	 δ	 ppm	 23.5,	 25.8,	 27.0,	 36.7,	 76.7,	 81.1,	 155.4,	
170.4,	 172.3;	 IR	 (solid	 state,	 cm-1)	 3274	 (N-H),	 1707	 (C=O	 ester);	 ESI-MS	 m/z	 found	
326.1685	[M+Na]+,	[C13H25N3O5Na]+	requires	326.1686	
(S)-tert-butyl	 2-(2-	 (((9H-fluoren-9-yl)	 methoxy)	 carbonylamino)-5-	 tert-	
butoxy-5-oxopentanoyl)	hydrazinecarboxylate,	61c		
	
Fmoc	 Glu(OtBu)COOH	 (3.00	 g,	 7.05	 mmol),	 HATU	 (2.95	 g,	 7.76	 mmol),	 tert-butyl	
carbazate	 (2.80	 g,	 21.2	 mmol)	 and	 diisopropylethylamine	 (2.46	 mL,	 14.1	 mmol)	 in	
anhydrous	dimethylformamide	(20	mL)	were	stirred	under	a	nitrogen	atmosphere	for	18	



































(S)-tert-butyl	 2-(2-(((9H-fluoren-9-yl)	 methoxy)	 carbonylamino)	 -5-	 tert-	 butoxy-5-
oxopentanoyl)	hydrazinecarboxylate,	61c	 (650	mg,	1.20	mmol)	 in	20	%	diethylamine	 in	
acetonitrile	(50	mL)	was	stirred	for	16	hours.	The	reaction	solution	was	then	concentrated	









Ethyl	 2-({4-[7,12,17-tris	 ({4-[(2-ethoxy-2-oxoethyl)	 carbamoyl]	 phenyl})-











































diluted	with	 dichloromethane	 (50	mL)	 and	washed	 successively	with	 saturated	 sodium	
hydrogen	 carbonate	 solution	 (100	mL),	 1	M	hydrochloric	 acid	 (100	mL)	 and	brine	 (100	
mL).	 The	organic	 phase	was	dried	 (sodium	 sulfate)	 and	 concentrated	 to	 yield	 the	 crude	









carbamoyl}	 phenyl)-21,22,23,24-	 tetraazapentacyclo	 [16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]	




O-tert-butyl-L-serine	 methyl	 ester	 hydrochloride	 (85	 mg,	 0.402	 mmol),	 and	
diisopropylethylamine	 (0.14	 mL,	 0.40	 mmol)	 in	 anhydrous	 dimethylformamide	 (5	 mL)	
were	 stirred	under	 a	 nitrogen	 atmosphere	 for	 18	hours.	 The	 reaction	mixture	was	 then	
dissolved	in	ethyl	acetate	(50	mL)	and	washed	with	saturated	sodium	hydrogen	carbonate	

































128.5,	 131.2,	 133.6,	 134.7,	 145.5,	 167.2,	 171.2;	 IR	 (solid	 state,	 cm-1)	 3314	 (N-H),	 1741	
(C=O	 ester),	 1656	 (C=O	 amide);	 ESI-MS	 m/z	 found	 1419.6575	 [M+H]+,	 [C80H90N8O16]+	
requires	1419.6553	
4-[7,12-Bis(4-{[(1R)-2-(tert-butoxy)-1-{N'-[(tert-butoxy)	 carbonyl]	 hydrazine	
carbonyl}	 ethyl]	 carbamoyl}	 phenyl)-17-(4-{[(1S)-2-(tert-butoxy)-1-{N'-[(tert-









then	 diluted	 with	 ethyl	 acetate	 (50	 mL)	 and	 washed	 with	 saturated	 sodium	 hydrogen	
carbonate	 solution	 (50	mL),	 1	M	hydrochloric	 acid	 (50	mL)	 and	brine	 (3	 x	 50	mL).	 The	
organic	phase	was	dried	(sodium	sulfate)	and	concentrated	to	yield	the	crude	product	as	a	
purple	 solid.	 This	 was	 purified	 by	 flash	 column	 chromatography	 (1:1	 ethyl	
































27.5,	 38.4,	 53.3,	 61.6,	 74.0,	 80.8,	 106.6,	 119.3,	 125.8,	 133.4,	 134.4,	 145.2,	 156.2,	 168.4,	
170.8;	IR	(solid	state,	cm-1)	3251	(N-H),	1696	(C=O	carbamate),	1645	(C=O	amide);	ESI-MS	
m/z	found	1820.9402	[M+2H]+,	[C96H124N16O20]+	requires	1820.9178	
4-	 [7,12-Bis	 (4-	 {[(1R)	 -2-	 hydroxy-1-	 {N'-	 [(1E)-	 phenylmethylidene]	
hydrazinecarbonyl}	 ethyl]	 carbamoyl}	 phenyl)-17-(4-{[(1S)-2-hydroxy-1-{N'-[(1E)-
phenylmethylidene]	 hydrazinecarbonyl}	 ethyl]	 carbamoyl}	 phenyl)-21,22,23,24-
tetraazapentacyclo	 [16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]	 tetracosa-1,3(24),4,6,8,10,12,14,16(22),	




ethyl]	 carbamoyl}	 phenyl)-17-(4-	 {[(1S)-2-	 (tert-butoxy)	 -1-{N'-[(tert-butoxy)	 carbonyl]	




(0.25	 mL)	 was	 stirred	 for	 6	 hours.	 The	 solution	 was	 then	 concentrated	 to	 yield	 the	
deprotected	hydrazide	as	a	green	solid	(complete	deprotection	was	confirmed	by	HRMS).		
The	 green	 solid	 was	 then	 redissolved	 in	 water	 (2	 mL)	 and	 acetonitrile	 (2	 mL)	 and	















































state,	 cm-1)	 3212	 (N-H),	 1633	 (C=O	 amide),	 1608	 (C=N);	 ESI-MS	m/z	 found	 1547.5750	
[M+H]+,	[C88H75N16O12]+	requires	1547.5340	
Tert-butyl	 (3S)-3-({4-	 [7,12-bis	 (4-{[(1R)-3-	 (tert-butoxy)-1-	 {N'-	 [(tert-
butoxy)carbonyl]	 hydrazinecarbonyl}-3-oxopropyl]	 carbamoyl}phenyl)-17-(4-
{[(1S)	 -3-	 (tert-butoxy)	 -1-{N'-[(tert-butoxy)	 carbonyl]	 hydrazinecarbonyl}	 -3-
oxopropyl]	 carbamoyl}	 phenyl)	 -21,22,23,24-	 tetraazapentacyclo	
[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3(24),4,6,8,10,	 12,14,16(22),17,19-undecaen-2-
yl]	 phenyl}	 formamido)-	 3-	 {N'-[(tert-butoxy)carbonyl]	 hydrazinecarbonyl}	
propanoate,	78b	
	
Tetracarboxyphenyl	 porphyrin	 (43	mg,	 0.055	mmol),	 PyBOP	 (172	mg,	 0.330	mmol),	
(S)-tert-butyl	 2-(2-amino-4-tert-butoxy-4-oxobutanoyl)hydrazinecarboxylate,	 62b	 (100	
mg,	 0.330	 mmol)	 and	 anhydrous	 diisopropylethylamine	 (0.11	 mL,	 0.66	 mmol)	 in	
anhydrous	dimethylformamide	(5	mL)	were	stirred	under	a	nitrogen	atmosphere	 for	18	
hours.	The	reaction	mixture	was	then	diluted	with	ethyl	acetate	(50	mL)	and	washed	with	
saturated	 sodium	hydrogen	 carbonate	 solution	 (50	mL),	 1	M	hydrochloric	 acid	 (50	mL)	
and	brine	(3	×	50	mL).	The	organic	phase	was	dried	(sodium	sulfate)	and	concentrated	to	
yield	 the	 crude	 product	 as	 a	 purple	 solid.	 This	 was	 purified	 by	 flash	 column	
































13C	NMR	 (101	MHz,	MeOD	+	10%	CDCl3)	 δ	 ppm	27.4,	 27.6,	 37.2,	 49.3,	 80.9,	 81.5,	 119.3,	
125.9,	 133.2,	 134.4,	 145.4,	 149.5,	 156.3,	 168.4,	 170.2,	 171.3,	 185.1;	 IR	 (solid	 state,	 cm-1)	
3275	 (N-H),	 1723	 (C=O	 ester),	 1711	 (C=O	 carbamate),	 1647	 (C=O	 amide);	 ESI-MS	m/z	
found	1931.9891	[M+H]+,	[C100H123N16O24]+	requires	1931.8896	
3(S)	 -3-	 ({4-	 [7,12-bis	 (4-	 {[(1R)	 -2-	 carboxy-1-	 {N'-	 [(1E)	 -phenylmethylidene]	
hydrazinecarbonyl}	ethyl]	carbamoyl}	phenyl)-17-	(4-	{[(1S)-2-carboxy-1-	{N'-[(1E)-
phenylmethylidene]	 hydrazinecarbonyl}ethyl]	 carbamoyl}	 phenyl)-21,22,23,24-
tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3(24),4,6,8,10,12,14,16(22),	







undecaen-2-yl]	 phenyl}	 formamido)	 -3-{N'-	 [(tert-butoxy)	 carbonyl]	 hydrazinecarbonyl}	




















































1714	 (C=O	acid),	 1643	 (C=O	amide),	 1607	 (C=N);	ESI-MS	m/z	 found	1659.5058	 [M+H]+,	
[C92H75N16O16]+	requires	1659.5547	
Tert-butyl	 (4S)	 -4-	 ({4-	 [7,12-	 bis	 (4-	 {[(1R)-4-	 (tert-butoxy)	 -1-	 {N'-	 [(tert-
butoxy)carbonyl]	 hydrazinecarbonyl}-4-oxobutyl]carbamoyl}phenyl)-17-(4-{[(1S)-
4-	 (tert-butoxy)	 -1-	 {N'	 -[(tert-butoxy)	 carbonyl]	 hydrazinecarbonyl}	 -4-	 oxobutyl]	





(S)-tert-butyl	 2-(2-amino-5-tert-butoxy-5-oxopentanoyl)hydrazinecarboxylate,	 62c	 (100	
mg,	 0.315	 mmol)	 and	 diisopropylethylamine	 (0.11	 mL,	 0.63	 mmol)	 in	 anhydrous	
dimethylformamide	 (5	 mL)	 were	 stirred	 under	 nitrogen	 for	 18	 hours.	 The	 reaction	
mixture	was	then	diluted	with	ethyl	acetate	(50	mL)	and	washed	with	saturated	sodium	
hydrogen	carbonate	 solution	 (50	mL),	1	M	hydrochloric	 acid	 (50	mL)	and	brine	 (3	x	50	
mL).	 The	organic	 phase	was	dried	 (sodium	 sulfate)	 and	 concentrated	 to	 yield	 the	 crude	



































H),	 1723	 (C=O	 ester),	 1643	 (C=O	 carbamate),	 1608	 (C=O	 amide);	 ESI-MS	 m/z	 found	
1988.0341	[M+H]+,	[C104H131N16O24]+	requires	1987.9522	




17,19-undecaen-2-yl]	 phenyl}	 formamido)	 -4-{N'-	 [(1E)-	 phenylmethylidene]	
hydrazinecarbonyl}	butanoic	acid,	79c	
	
Tert-butyl	 (4S)	 -4-	 ({4-	 [7,	 12-bis	 (4-{[(1R)-4-	 (tert-	 butoxy)-1-	 {N'-[(tert-	 butoxy)	
carbonyl]	 hydrazinecarbonyl}-4-oxobutyl]	 carbamoyl}	 phenyl)	 -17-	 (4-	 {[(1S)-4-	 (tert-
butoxy)-1-{N'-[(tert-butoxy)carbonyl]hydrazinecarbonyl}-4-oxobutyl]carbamoyl}phenyl)-
21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3(24),4,6,8,10,12,14,	16	
(22),	 17,19-undecaen-2-yl]	 phenyl}	 formamido)-4-{N'-[(tert-butoxy)carbonyl]	 hydrazine	
carbonyl}	 butanoate,	78b	 (30	mg,	 	 0.015	mmol)	 in	 trifluoroacetic	 acid	 (4.5	mL),	 water	
(0.25	mL)	and	triisopropylsilane	(0.25	mL)	was	stirred	for	6	hours.	The	solution	was	then	
concentrated	 to	 yield	 the	 deprotected	 hydrazide	 porphyrin	 as	 a	 green	 solid	 (complete	
deprotection	was	confirmed	by	HRMS).		The	green	solid	was	then	redissolved	in	water	(2	
mL)	and	acetonitrile	(2	mL)	and	benzaldehyde	(2	drops)	was	added,	the	mixture	was	then	
stirred	 for	 30	 minutes.	 The	 precipitate	 was	 isolated	 and	 washed	 with	 water	 and	













































H13’),	 11.52	 (m,	 2	 H,	 H10),	 11.68	 (m,	 2	 H,	 H10’),	 12.33	 (br.	 s,	 4	 H,	 OH)	 (cis	 and	 trans	
isomers	of	hydrazone	observed	in	1:1	ratio);	IR	(solid	state,	cm-1)	3283	(N-H),	1633	(C=O	
















1-[2-oxo-2-(pyridin-2-yl)ethyl]pyridin-1-ium	 iodide,	 83	 (5.00	 g,	 15.3	 mmol),	
methacrolein	 (1.26	 mL,	 15.3	 mmol)	 and	 ammonium	 acetate	 (4.72	 g,	 61.2	 mmol)	 in	






























121.4,	 122.1,	 123.7,	 124.8,	 127.1,	 148.4,	 148.9,	 149.1,	 155.8,	 156.2;	 IR	 (solid	 state,	 cm-1)	




5-Methyl-2-(pyridin-2-yl)pyridine,	 85	 (750	 mg,	 4.41	 mmol)	 and	 potassium	
permanganate	 (2.79	g,	17.6	mmol)	 in	water	were	heated	under	 reflux	 for	16	hours.	The	
solution	was	then	cooled	to	room	temperature	and	filtered	through	celite.	The	filtrate	was	
made	 basic	 by	 addition	 of	 1	 M	 sodium	 hydroxide	 solution,	 and	 washed	 with	
dichloromethane	 (100	mL).	 The	 aqueous	 phase	was	 acidified	 by	 addition	 of	 acetic	 acid,	




H6),	 9.25	 (s,	 1	 H,	 H7);	 13C	NMR	 (126	MHz,	 DMSO-d6)	 δ	 ppm	 120.2,	 121.2,	 124.9,	 127.1,	




























was	 extracted	with	 dichloromethane	 (100	mL)	 and	 the	 organic	 phase	washed	with	 1	M	
hydrochloric	acid	(50	mL)	and	brine	(50	mL),	dried	(sodium	sulfate)	and	concentrated	to	
yield	 the	 product	 as	 a	 pale	 pink	 solid	 (425	mg,	 1.99	mmol,	 79	%);	 1H	 NMR	 (500	MHz,	
CDCl3)	δ	ppm	3.98	(s,	3H,	H8),	7.40	(dd,	J	=	7.4,	5.2	Hz,	1	H,	H2),	7.89	(td,	J	=	7.4,	1.4	Hz,	1	H,	
H3),	8.44	(dd,	J	=	8.3,	2.0	Hz,	1	H,	H6),	8.52	(d,	J	=	7.4	Hz,	1	H,	H4),	8.55	(d,	J	=	8.3	Hz,	1	H,	
H5),	 8.75	 (br.	 s,	 1	H,	H1),	 9.30	 (br.	 s,	 1	H,	H7);	 13C	NMR	 (126	MHz,	 CDCl3)	 δ	 ppm	52.4,	
117.2,	120.6,	124.5,	125.7,	137.1	138.1,	149.4,	150.5,	155.1,	159.5,	165.9;	 IR	 (solid	state,	
cm-1)	 1716	 (C=O	 ester);	 ESI-HRMS	 found	m/z	 	 215.0821	 [M+H]+,	 [C12H10N2O2]+	 requires	
215.0821	
Tris	 (methyl	 6-	 (pyridin-2-yl)	 pyridine	 -3-	 carboxylate)	 ruthenium(II)	
dihexafluorophosphate,	87	
	
Methyl	 6-(pyridin-2-yl)pyridine-3-carboxylate,	 86	 (250	 mg,	 1.17	 mmol),	
Ru(II)(DMSO)4Cl2	 (177	 mg,	 0.364	 mmol),	 and	 silver	 nitrate	 (171	 mg,	 0.728	 mmol)	 in	
ethanol	 (20	 mL)	 were	 heated	 under	 reflux	 for	 6	 days.	 The	 reaction	 mixture	 was	 then	
filtered	 through	celite,	and	 the	celite	pad	washed	 thoroughly	with	dichloromethane.	The	
filtrate	was	then	concentrated	and	the	resulting	red	solid	redissolved	in	water.	An	excess	
of	 ammonium	 hexafluorophosphate	was	 added	 and	 the	 red	 precipitate	 isolated	 to	 yield	
the	product	as	a	 red	solid	 (308	mg,	0.298	mmol,	82	%);	 1H	NMR	(500	MHz,	DMSO-d6)	δ	
ppm	3.18	(s,	4.5	H,	H8),	3.80	(s,	4.5	H,	H8),	7.60	(m,	3	H,	H2),	7.82	(m,	3	H,	H3),	7.05(m,	3	
H,	H6),	8.24	(m,	3	H,	H4),	8.55	(m,	3	H,	H5),	8.95	(m,	6	H,	H1+H7)	(fac	and	mer	 isomers	






























Tris	 (methyl	 6-	 (pyridin-2-yl)	 pyridine-3-	 carboxylate)	 ruthenium(II)	
dihexafluorophosphate,	87	 (400	mg,	 0.387	mmol)	was	 stirred	 in	1	M	 sodium	hydroxide	
solution	 and	 ethanol	 for	 2	 hours.	 The	 reaction	 mixture	 was	 then	 concentrated	 and	
redissolved	 in	 water.	 The	 resulting	 solution	 was	 neutralized	 by	 addition	 of	 1	 M	
hydrochloric	acid	and	concentrated.	The	salt	was	removed	by	dissolving	 the	red	solid	 in	









6-(pyridin-2-yl)pyridine-3-carboxylic	 acid	 (200	mg,	 1.00	mmol)	 	 in	 thionyl	 chloride	
(10	mL)	was	heated	under	reflux	for	16	hours.	The	solvent	was	then	removed	in	vacuo	and	




was	 then	heated	under	reflux	 for	16	hours.	The	reaction	mixture	was	 then	washed	with	
saturated	 sodium	hydrogen	 carbonate	 solution	 (50	mL),	 1	M	hydrochloric	 acid	 (50	mL)	
and	 brine	 (50	mL).	 The	 organic	 phase	 was	 dried	 (sodium	 sulfate)	 and	 concentrated	 to	



























14.5,	 6.9	 Hz,	 1	 H,	 H3),	 9.16	 (s,	 1	 H,	 H7);	 IR	 (solid	 state,	 cm-1)	 3273	 (N-H),	 1699	 (C=O	




1-[2-Oxo-2-(pyridin-2-yl)ethyl]pyridin-1-ium	 iodide,	 83	 (4.04	 g,	 12.4	 mmol),	














5-Methyl-2-(pyridin-2-yl)pyridine,	 89	 (450	 mg,	 2.64	 mmol)	 and	 potassium	







































H,	H1),	8.76	 (d,	 J	=	5.0	Hz,	1	H,	H6),	8.87	 (s,	1	H,	H5);	 13C	NMR	(126	MHz,	CDCl3)	δ	ppm	
52.7,	120.4,	121.3,	122.8,	124.2,	137.0,	138.5,	149.4,	150.0,	155.4,	157.4,	165.8;	 IR	 (solid	
state,	 cm-1)	 1720	 (C=O	 ester);	 ESI-HRMS	 found	 m/z	 215.0817	 [M+H]+,	 [C12H10N2O2]+	
requires	215.0821	
Tris	 (methyl	 2-	 (pyridin-2-yl)	 pyridine	 -4-	 carboxylate)	 ruthenium(II)	
dihexafluorophosphate,	92	
	
Methyl	 2-(pyridin-2-yl)pyridine-4-carboxylate,	 91	 (200	 mg,	 0.934	 mmol),	
Ru(II)(DMSO)4Cl2	(141	mg,	 0.292	mmol),	 silver	 nitrate	 (99	mg,	 0.58	mmol)	 and	 ethanol	
(25	 mL)	 were	 heated	 under	 reflux	 for	 7	 days.	 The	 resulting	 mixture	 was	 cooled	 and	
filtered	through	celite.	The	celite	pad	was	then	washed	with	dichloromethane	until	all	of	
the	 red	 compound	 had	 washed	 through.	 The	 filtrate	 was	 then	 concentrated	 and	 the	






























Tris	 (methyl	 2-(pyridin-2-yl)pyridine-4-carboxylate)	 ruthenium(II)	 dihexafluoro-

















used	cyt	c	 oxidized	with	K3Fe(CN)6	 followed	by	dialysis	 into	5	mM	sodium	phosphate,	2	
mM	sodium	ascorbate,	pH	7.5	buffer,	to	remove	the	excess	K3Fe(CN)6.	The	concentration	














In	 all	 assays	 the	 Ru(II)(bpy)3	 complex	 concentration	 was	 kept	 constant,	 with	 the	
concentration	 of	 cyt	 c	 being	 varied	 through	 the	 assay,	 as	 described	 below.	 Results	
obtained	were	fitted,	using	OriginPro	9,	to	a	1:1	binding	isotherm	(Eq.	6.1).	 	
	 	 	 	 	 	
	 	 	 	 𝐼 =  ![ !!!!! ! (!!!!!)
!!!!"
!!
	 	 	 Eq.	6.1	
Where	I	=	change	in	relative	luminescence	intensity	(I/I0),	m	=	maximum	value	of	I,	a	=	




were	 taken	 in	 a	 4	mL	quartz	 cuvette	with	 excitation	 at	 467	nm	and	 emission	measured	





3. 10	 μL	 of	 a	 solution	 with	 an	 appropriate	 cyt	 c	 concentration	 with	 the	 same	




















μM	 Ru(II)(bpy)3	 complex	 in	 5	mM	 sodium	 phosphate	 buffer,	 pH	 7.5.	 100	 μL	 of	 10	mM	
ascorbate	 in	 5	 mM	 sodium	 phosphate,	 pH	 7.5	 was	 added,	 and	 the	 spectrophotometer	




Sensitivity	 enhanced	 1H-15N	 HSQC	 NMR	 correlation	 spectra	 of	 ligand-bound	 and	
unbound	 forms	of	 horse	heart	 cyt	 c,	 purchased	 from	Sigma	Aldrich,	were	 carried	 out	 at	
natural	 abundance	using	 a	 950	MHz	Bruker	AscendTM	Aeon	 spectrometer	 operating	 at	 a	




cyt	 c	 and	0.5	mM	Ru(II)(bpy)3	 complex	were	used,	 to	 a	 total	 volume	of	 600	μL.	 Spectra	
were	 analysed	 using	 the	 CcpNmr	 Analysis	 software	 package	 and	 the	 chemical	 shift	
perturbations	were	calculated	as	the	square	root	of	the	sum	of	the	isotope	weighted	shift	
differences	squared	(Eq.	6.2),	
	 	 	 	 Δ𝛿 = (Δ𝛿!)! +
𝛾! 𝛾!
!
(Δ𝛿!)!	 	 Eq.	6.2	 	





All	hydrazone	exchange	 reactions	were	 carried	out	 in	HPLC	vials	 and	were	 followed	
using	 high	 resolution	 mass	 spectrometry,	 using	 a	 Bruker	 Daltonics	 micrOTOF	 Premier	
Mass	Spectrometer,	using	10	μL	injections	and	summing	the	masses	over	the	range	1.0	to	
3.0	 minutes.	 The	 intensity	 of	 the	 maximum	 peak	 for	 each	 of	 the	 successive	 hydrazone	
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In	 hydrazone	 exchange	 reactions	 1	 mL	 of	 100	 μM	 Ru(II)(bpy)3	 hydrazone	 complex	
46a,	10	mM	aldehyde	and	10	mM	aniline	 in	1:1	acetonitrile	water	were	 incubated	 in	an	
HPLC	vial	and	mass	spectra	were	obtained	at	appropriate	time	periods.	
6.3.2 Porphyrins	
Hydrazone	 functionalised	 porphyrins	 79	 were	 made	 up	 to	 5	 mM	 concentration	 in	
DMSO	 and	 were	 stored	 in	 plastic	 Eppendorf	 tubes.	 1	 M	 stocks	 of	 catalyst	 (aniline	 and	
anthranillic	 acid)	 and	 aldehydes	 (2,4-dimethoxy	benzaldehyde,	 4-carboxy	benzaldehyde,	
4-methyl	 ester	 benzaldehyde)	 were	 made	 up	 in	 DMSO.	 	 4-hydoxy	 benzaldehyde	 stock	
were	made	up	to	0.5	M	in	DMSO.		
6.3.2.1 Hydrazone	exchange	reactions	
In	 all	 exchange	 reactions	 the	 hydrazone	 functionalised	 porphyrin	 79	 in	 DMSO	 was	
added	 to	 a	 solution	 of	 the	 aldehyde	 and	 catalyst	 to	 give	 a	 total	 concentration	 of	 10	%	
DMSO	in	5	mM	ammonium	acetate	buffer,	pH	6.75,	 to	a	 final	porphyrin	concentration	of	
100	μM	and	 stated	 concentrations	of	 other	 components.	 For	 time	 courses,	mass	 spectra	
were	obtained	at	appropriates	time	points	(usually	0.5,	1,	2,	4,	6,	9,	12	and	24	hours).	For	
measurements	 at	 single	 time	 points,	 mass	 spectra	 were	 obtained	 after	 24	 hours	
incubation.	For	pre-incubated	 samples,	 the	pre-incubated	mixture	was	 left	 for	24	hours,	
and	a	mass	spectrum	obtained,	prior	to	addition	of	further	components.	
6.3.2.2 Protein	incubation	
A	 200	 µL	 solution	 containing	 100	 µM	 benzaldehyde	 hydrazone	 porphyrin	79,	 2.5	
mM	of	any	aldehyde,	10	mM	aniline	in	10	%	DMSO	in	5	mM	NH4OAc,	pH	6.75	buffer	was	
incubated	 for	 24	 hours.	 At	 which	 point	 20	 µL	 of	 1	 mM	 protein	 stock	 in	 5	 mM	 sodium	
phosphate,	pH	7.5	buffer	or	5	mM	sodium	phosphate,	pH	7.5	buffer	alone	(for	no	protein	




All	 arrays	 were	 performed	 in	 5	 mM	 sodium	 phosphate,	 pH	 7.5	 buffer.	 All	 protein	
stocks,	other	 than	Mcl-1	and	hDM2,	were	made	up	 from	freeze-dried	protein,	purchased	
















To	 each	 well	 was	 added	 20	 μL	 of	 7.5	 μM	 Ru(II)(bpy)3	 complex	 solution	 (or	 5	 mM	
sodium	 phosphate	 buffer,	 pH	 7.5),	 20	 μL	 of	 30	 μM	 protein	 solution	 (or	 5	 mM	 sodium	
phosphate,	 pH	 7.5	 buffer)	 and	 20	 μL	 of	 1.5	 μM	 FITC-NOXA-B	 (R-A)	 peptide	 (or	 5	 mM	
sodium	 phosphate,	 pH	 7.5	 buffer).	 On	 each	 plate	 wells	 without	 protein	 were	 run	 in	
quadruplicate.	The	plate	was	 incubated	 for	2	and	20	hours	prior	 to	scanning	using	 fixed	
wavelengths,	excitation	467	nm,	emission	630	nm,	and	using	monochromators,	excitation	
467	 nm,	 emission	 range	 480	 -	 750	 nm,	 3	 nm	 step,	 100	 flashes.	 The	 peak	
maxima/intensities	 for	both	 luminescence	bands	were	 taken	(emission	520	nm	and	630	








Microsoft	Excel	was	used	 to	calculate	 the	percentage	differences	 from	no	protein	 for	
each	 of	 the	 individual	 wells.	 Linear	 discriminant	 analysis	 was	 carried	 out	 using	 XLstat	
software,	 then	 plotted	 using	 OriginPro	 9.	 Confidence	 ellipses	 were	 obtained	 using	
OriginPro	9.4.	




and	 aldehyde	 (4-carboxy	 benzaldehyde,	 2,4-dimethoxy	 benzaldehyde,	 4-hydroxy	
benzaldehyde,	 2,4-dihydroxy	 benzaldehyde,	 furfural,	 4-nitro	 benzldehyde,	 tert-butoxy	
benzaldehyde,	 benzaldehyde,	 3-pyridine	 carboxaldhyde,	 4-chloro	 benzaldehyde)	 stocks	
were	made	 up	 to	 100	mM	 in	DMSO.	 	 Protein	 stocks	were	made	 up	 to	~1	mM	 in	 5	mM	
sodium	phosphate,	pH	7.5	and	concentrations	measured	as	for	Chapter	4.	
DCC	arrays	were	set	up	in	96	well	plates	(Optiplate)	in	triplicate.	In	each	well	250	μL	
of	 50	 μM	 glycine	 hydrazide	 complex,	 10	mM	 aniline,	 300	 μM	 each	 aldehyde	 and	 50	 μM	
protein	in	10	%	DMSO	in	50	mM	ammonium	acetate,	pH	6.2	buffer		was	incubated	for	18	
hours	at	room	temperature.	At	which	point	the	reaction	was	quenched	by	addition	of	4	μL	
of	 1	 M	 NaOH.	 The	 contents	 of	 each	 well	 were	 transferred	 to	 a	 vivaspin	 500	 protein	
concentrator	MWCO	5	kDa,	and	centrifuged	at	13	000	g	for	22	minutes.	4	μL	of	1	M	NaOH	
followed	 by	 200	 μL	 of	 NH4OAc,	 pH	 6.2	 buffer	 was	 added	 to	 the	 concentrate	 and	 the	
concentrator	 centrifuged	 at	 8	 000	 g	 for	 40	minutes.	 The	 flow	 through	was	 analysed	 by	
analytical	 HPLC	 (Rapid	 5-95	 Methanol+TFA	 gradient	 using	 an	 Ascentis	 Express	 C18	
column)	 at	 280	 nm,	 and	 the	 peak	 integrations	 for	 the	major	 peaks	 taken	 and	 used	 for	
analysis.	




10	 mM	 ammonium	 hydroxide	 solution,	 or	 in	 5	 mM	 sodium	 phosphate,	 pH	 7.5.	 The	
accurate	peptide	 concentration	was	determined	by	UV/Vis	 absorption	at	280	nm	 (ε	=	
1490	M-1	cm-1	for	both	peptides).	Ru(II)(bpy)3	complex	stocks	were	made	up	to	1	mM	in	











between	 the	 temperature	 increase	 and	 obtaining	 the	 CD	 spectra.	 A	 final	 spectrum	was	
obtained	after	the	chamber	had	cooled	to	20	°C.	The	ellipticity	at	222	nm	(corresponding	
to	helical	content)	was	used	to	calculate	the	fraction	folded	(Eq.	6.3).	
	 	 	 	 	 𝛼 = ! ! !!!
!!!!!











In	 order	 to	 see	 how	 this	 can	 provide	 information	 on	 the	 binding	 between	 the	 two	
species,	 it	 is	 first	 necessary	 to	 understand	 the	 fundamentals	 of	 chemical	 reaction	













	 	 	 	 	𝑎! = 𝛾!
!!
!!
!	 	 	 	 	 Eq.	7.3	
Combining	Eq.	6.2	and	Eq.	6.3	 	 	 	 	 	 	 	
	 	 	 	 𝜇! = 𝜇!! + 𝑅𝑇𝑙𝑛
!!
!!
! + 𝑅𝑇𝑙𝑛𝛾! 	 	 	 Eq.	7.4	




	 	 		 	 𝜇! = 𝜇!! + 𝑅𝑇𝑙𝑛𝛾! 	 	 	 	 Eq.	7.5	
This	equation	can	then	be	put	back	into	Eq.	6.1	
	 	 𝛥𝐺 = 𝜇!! + 𝜇!! − 𝜇!! + 𝑅𝑇𝑙𝑛𝛾! + 𝑅𝑇𝑙𝑛𝛾! − 𝑅𝑇𝑙𝑛𝛾! 	 	 Eq.	7.6	
As	 	 	 𝛥𝐺! = 𝜇!! + 𝜇!! − 𝜇!.!! 	 	 	 	 	 Eq.	7.7	
Then	 	 	 𝛥𝐺 = 𝛥𝐺! + 𝑅𝑇𝑙𝑛𝛾! + 𝑅𝑇𝑙𝑛𝛾! − 𝑅𝑇𝑙𝑛𝛾!.! 	 	 Eq.	7.8	
Simplifying		 	 𝛥𝐺 = 𝛥𝐺! + 𝑅𝑇𝑙𝑛 !!!!
!!.!
		 	 	 	 Eq.	7.9	
Inputting	the	Gibbs	free	energy	isotherm-	 	 	 	 	 	
	 	 	 𝛥𝐺 = −𝑅𝑇𝑙𝑛𝐾	 	 	 	 	 	 Eq.	7.10	
Gives		 	 	 −𝑅𝑇𝑙𝑛𝐾 = −𝑅𝑇𝑙𝑛𝐾! + 𝑅𝑇𝑙𝑛 !!!!
!!.!
		 	 	 Eq.	7.11	
Simplifying	this	gives	 𝑙𝑛𝐾 = 𝑙𝑛𝐾! − 𝑙𝑛 !!!!
!!.!
	 	 	 	 	 Eq	7.12	
In	an	ideal	(infinitely	dilute)	solution	or	gas,	the	γ	values	are	1,	thus	making	
	 	 	 𝑙𝑛𝐾 = 𝑙𝑛𝐾!	 	 	 	 	 	 Eq.	7.13	
An	ionic	solution,	however	is	not	ideal	and	γ	≠	1,	therefore	we	need	to	compute	values	for	
γ,	 this	 is	done	using	the	Debye-Hückel	approximation,208,209	where	 it	 is	assumed	that	 the	
activities	(a)	or	activity	coefficients	(γ)	are	assumed	to	be	dependent	on	the	ionic	strength	
of	the	solution	(I)	and	not	on	the	composition	of	the	solution.		
The	Debye-Hückel	approximation-	 𝑙𝑜𝑔!"𝛾 = − 𝑧!𝑧! 𝐴 𝐼 !/!	 	 Eq.	7.14	








	 	 	 	 Eq.	7.15	
	 161	
And	 	 		 	 𝑙𝑜𝑔!"𝛾!" =
! !!!! !
!! !
	 	 	 Eq.	7.16	





	 	 	 Eq.	7.17	





	 	 	 Eq.	7.18	
Inputting	Eq.	and	Eq.	into	Eq.	6.13	for	the	dissociation	reaction	



































peaks	 present	 in	 the	mass	 spectrum,	 and	 also	 potentially	 increase	 the	 rate	 of	 reaching	






The	 Wilson	 group	 have	 previously	 reported	 the	 use	 of	 5’	 monosubstituted	
Ru(II)(bpy)3	complexes	for	binding	to	cyt	c.143	It	was	therefore	decided	to	synthesise	a	5’	
acid	complex,	via	a	similar	synthetic	route	(Scheme	7.1).	The	synthesis	uses	a	Kroehnke	
method210,211	 to	 access	 the	 bipyridine	 by	 reaction	 of	 the	 Kroehnke	 reagent	 83	 with	
methacrolein	84	to	give	a	5’	methyl	substituted	bipyridine	85.	This	can	be	oxidised	to	the	
corresponding	carboxylic	acid	69	with	potassium	permanganate,	followed	by	methyl	ester	
formation	 to	 form	 86,	 ruthenium(II)	 complexation	 to	 give	 87	 and	 subsequent	
deprotection,	to	yield	the	5’	acid	Ru(II)(bpy)3	complex	65.	
7.2.2 4’	monosubstituted	bipyridine	complex	synthesis	
While	 the	5’	 bipyridine	Ru(II)(bpy)3	 complexes	have	been	used	 in	 the	Wilson	 group	
previously,143	 4’	 bipyridines	 have	 not	 been	 reported	 by	 the	 group.	 However,	 the	 4’	
substituted	 Ru(II)(bpy)3	 complexes	 offer	 advantages	 over	 the	 corresponding	 5’	
substituted	 Ru(II)(bpy)3	 complexes,	 including	 higher	 quantum	 yields	 of	 the	














































despite	 difficulties	 found	 in	 purification	 of	 the	 methyl	 ligand	 89.	 The	 same	 Kroehnke	
reagent	 83	 as	 in	 the	 5’	 substituted	 bipyridine	 synthesis	 was	 used,	 and	 reacted	 with	
crotonaldehyde	88.	 In	 the	 5’	 substituted	 2,2’-bipyridine	 synthesis	 the	methyl	 ligand	85	
could	 easily	 be	 purified	 by	 a	 filtration	 silica	 column,	 however	 the	 4’	 substituted	methyl	
ligand	 89	 stuck	 to	 the	 column	 and	 could	 not	 be	 eluted.	 Thus,	 in	 this	 case,	 the	 acid	
formation	and	subsequent	methyl	ester	formation	were	performed	crude,	with	the	methyl	
ester	ligand	91	purified	prior	to	ruthenium(II)	complexation.	Ruthenium(II)	complexation	













































A	 qualitative	 description	 of	 both	 principle	 component	 analysis	 (PCA)	 and	 linear	
discriminant	 analysis	 was	 presented	 in	 Chapter	 4.	 This	 appendix	 presents	 some	 of	 the	
mathematics	behind	these	techniques,	using	the	Ru(II)(bpy)3	complex-protein	array	as	an	
example,	where	appropriate.		
The	 aim	 of	 both	 of	 these	 analyses	 is	 to	 generate	 equations	 which	 give	 linear	
combinations	of	the	data	original	data,	e.g.	
	 	 	 	 𝑋 = 𝑎!𝐴 + 𝑏!𝐵 +⋯+ ℎ!𝐻	 	 	 Eq.	7.23	
Where	 A,	 B,	 …	 ,	 H	 are	 the	 luminescence	 responses	 from	 the	 different	 Ru(II)(bpy)3	
complexes	 and	 a1,	 b1,	 …	 ,	 h1	 are	 linear	 components	 used	 to	 generate	 the	 first	 principle	
component/linear	 discriminate,	 these	 are	 derived	 using	 the	 analysis.	 This	 equation	 can	
also	be	written	in	a	vector	format.		















Before	 using	 the	 more	 complicated	 mathematics	 it	 is	 necessary	 to	 define	 some	
statistical	variables.	
Mean	 	 𝜇! =
!
!
(𝑎! + 𝑎! +⋯+ 𝑎!)	 	 	 	 Eq.	7.25	
Variance																			𝑉𝑎𝑟 𝐴 = !
!!!
( 𝑎! − 𝜇! ! + 𝑎! − 𝜇! ! +⋯+ (𝑎! − 𝜇!)!)	
	 	 	 	 	 	 	 	 	 	 Eq.	7.26	
Covariance		 𝐶𝑜𝑣 𝐴,𝐵 = !
!!!
( 𝑎! − 𝜇! 𝑏! − 𝜇! +⋯+ 𝑎! − 𝜇! 𝑏! − 𝜇! )




































Using	 the	mean	vector	 it	 is	possible	 to	 recentre	 the	vectors	a,	b,	c,	 etc.	 around	0,	by	
subtracting	the	mean	vector,	μ	




𝑎! − 𝜇! 𝑏! − 𝜇!
𝑎! − 𝜇! 𝑏! − 𝜇!
⋯ 𝑥! − 𝜇!
⋯ 𝑥! − 𝜇!
⋮ ⋮
𝑎! − 𝜇! 𝑏! − 𝜇!
⋮ ⋮











	 	 	 𝐶𝒘𝒊 = 𝝀𝒊𝒘𝒊	 	 	 	 Eq.	7.29	
Where	λi	=	eigenvalue,	and	wi=	the	corresponding	eigenvector	
The	solutions	to	this	equation	will	give	x	eigenvectors	and	eigenvalues.	
These	eigenvalues	can	be	put	 into	magnitude	order	 (λ1	≥	λ2	≥	λ3	…	≥	λx	≥0).	 It	may	be	
that	 a	 small	 number	 (2	 or	 3)	 of	 the	 eigenvalues	 are	 much	 larger	 than	 the	 other	






























	 	 	 	 𝑀 = 𝑀!!!!! 	 	 	 	 Eq.	7.30	
Where	C	is	the	total	number	of	classes	
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From	 these	parameters	 it	 is	possible	 to	define	 two	scatter	matrices,	 the	within	 class	
scatter	matrix	(Sw)	and	the	between	class	scatter	matric	(SB).	




!!! 	 	 	 														Eq.	7.31	
𝑆! = (𝝁𝒊 − 𝝁)(𝝁𝒊 − 𝝁)!!!!! 	 	 	 	 														Eq.	7.32	
Where	μ	is	the	mean	of	the	whole	data	set-				𝝁 = !
! 
 𝝁𝒊!!!! 		 													Eq.	7.33	
These	scatter	matrices	can	be	transformed	onto	new	planes	(W)	using	the	equations-	
	 	 	 	 	 𝑆! = 𝑊𝑻𝑆!𝑊	 	 	 	 Eq.	7.34	
																																																																				𝑆! = 𝑊𝑻𝑆!𝑊	 	 	 	 Eq.	7.35	
The	aim	of	LDA	is	to	find	an	optimal	W	(W*)	such	that	det	Sb/det	Sw	is	maximised,	i.e.	
finding	the	minimum	within	class	scatter	to	the	maximum	between	class	scatter.		
																																																															𝑊∗ = 𝑎𝑟𝑔𝑚𝑎𝑥 !
!!!!
!!!!!
	 	 	 Eq.	7.35	
This	 is	 found	 by	 finding	 a	 matrix	 W*	 whose	 columns	 are	 the	 eigenvectors	 (wi)	
corresponding	to	the	largest	eigenvalues	of	the	following	equation-	







7.4 Appendix	 IV-	 DCC	 array	 studies	 with	 hydrazone	 functionalised	
Ru(II)(bpy)3	complexes	
The	 arrays	 discussed	 in	 Chapter	 4,	 expand	 on	 previously	 reported	 luminescence	
arrays,	 using	 new	 types	 and	 combinations	 of	 molecules.	 However,	 recently	 the	 Waters	
group	 reported	 a	 study	 combining	 DCC	 and	 arrays,	 in	 order	 to	 distinguish	 different	
histone	post-translational	modification	states.187	This	brings	together	the	ideas	presented	
in	Chapter	3	and	Chapter	4.	 In	Chapter	3	 the	development	of	hydrazone-based	DCC	was	
discussed;	 this	 is	 a	 combinatorial	 approach	 whereby	 a	 range	 of	 potential	 candidates	 is	
sampled	in	order	to	find	ligands	for	a	particular	template	(like	a	protein).	The	discussion	
of	DCC	presented	 in	Chapter	3	was	 for	 the	generation	of	high	affinity	protein	 ligands,	by	
sampling	 a	 wide	 range	 of	 different	 potential	 candidates.	 However	 when	 using	 this	
approach,	it	could	be	that	potent	protein	ligands	are	not	generated,	for	example,	if	there	is	
not	a	potent	 ligand	within	 the	range	of	potential	candidates.	Even	 if	high	affinity	 ligands	





The	 glycine	 hydrazide	 Ru(II)(bpy)3	 complex	 49	 was	 used	 (Scheme	 7.3)	 in	 these	
studies;	 as	discussed	 in	Chapter	3	 the	hydrazones	of	 this	Ru(II)(bpy)3	 complex	50	were	
insoluble	 in	 DMSO/aqueous	mixtures,	 and	 hence	 the	 hydrazone	 exchange	 could	 not	 be	




Range of molecules present after incubation with protein
Range of molecules present without protein




	Firstly,	 incubations	 were	 performed	 with	 2	 and	 3	 different	 aldehydes	 (4-carboxy	
benzaldehyde	 44c,	 2,4-dimethoxy	 benzaldehyde	 44b	 and	 benzaldehyde	 44a),	 with	 the	
hydrazide	 Ru(II)(bpy)3	 complex	49,	 aniline	45	 and	 3	 different	 proteins	 (BSA,	 lysozyme	
and	 cyt	 c).	 After	 16	 hours	 incubation,	 attempts	 to	 separate	 the	 Ru(II)(bpy)3	 complexes	
formed	 from	 the	 proteins	 using	 protein	 concentrators	 (MWCO	 5	 kDa)	 were	 made,	
however	 due	 to	 the	 insolubility	 of	 the	 Ru(II)(bpy)3	 hydrazone	 complexes	 46	 they	
precipitated,	 staying	with	 the	 protein,	 rather	 than	 filtering	 through	 to	 the	 flow	 through	





the	 generation	 of	 high	 affinity	 protein	 ligands,	 analysis	 of	 the	 flow	 through	 from	 the	
protein	concentrator	would	yield	 information	as	 to	 the	aldehydes	present,	and	therefore	
those	not	used	to	form	hydrazones.	As	just	the	aldehydes	were	to	be	analysed,	rather	than	
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This	 experiment	 was	 performed	with	 both	 2	 equivalents	 and	 6	 equivalents	 of	 each	
aldehyde	 44	 per	 hydrazide	 Ru(II)(bpy)3	 complex	 49,	 and	 the	 aldehyde	 mixture	 in	 the	
protein	 concentrator	 flow	 through	 analysed	 by	 analytical	 HPLC.	 The	 peaks	 present	 at	
various	different	retention	times	were	analysed,	and	the	percentage	of	the	total	area	used.	
This	gave	a	fingerprint	bar	chart	for	the	proteins	(Figure	7.3)	similar	to	those	previously	
described	 for	 the	 luminescence	 arrays.	 Upon	 inspection	 of	 the	 bar	 charts	 very	 little	








7.4)	 was	 attempted,	 even	 though	 the	 fingerprints	 looked	 similar.	 This	 shows	 some	
clustering	of	the	data	points,	and	especially	in	the	case	of	using	6	equivalents	of	aldehyde	
44	shows	that	the	data	for	the	different	proteins	may	be	clustering	separately,	indicating	
that	 there	 is	 potential	 to	 use	 this	 technique	 for	 the	 discrimination	 of	 different	 proteins.	
However,	more	 data	would	 need	 to	 be	 obtained	 from	many	more	 replicates	 in	 order	 to	
determine	 if	 this	 is	 statistically	 significant,	 as	 well	 as	 controls	 without	 the	 Ru(II)(bpy)3	
hydrazide	complex	49	present	to	see	 if	 it	 is	 the	aldehydes	reacting	with	the	protein	that	









Thus	 far	 the	Ru(II)(bpy)3	 complexes	presented	have	been	studied	as	protein	 surface	
mimetics	for	use	in	PPI	inhibition	and	protein	sensing.	However,	another	potential	use	of	
protein	 surface	 mimetics	 is	 PPI	 stabilisation.	 Previously	 guanidine	 functionalised	
















the	 residues	 in	 the	 tetramerisation	 domain	 sequence	 were	 important	 for	 the	
tetramerisation,218	 implicating	 nine	 hydrophobic	 residues	 present	 in	 the	 core	 of	 the	
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tetramer.	 One	 of	 the	 amino	 acids	 implicated	 in	 this	 study	 was	 Arg-337;	 the	 R337A	
mutation	 resulted	 in	 a	 decreased	melting	 temperature	 (Tm)	 of	 39.2	 °C	 compared	 to	 the	
wild-type	 protein.	 A	 histidine	mutation	 in	 this	 position	 is	 the	most	 frequently	 inherited	
mutation	 affecting	 p53	 tetramerisation,219	 and	 results	 in	 increased	 chances	 of	 tumour	
























































Circular	 dichroism	 can	 be	 used	 to	 probe	 the	 secondary	 structure	 of	 peptides	 and	
proteins,	 showing	 their	 α-helical,	 β-sheet	 and	 random	 coil	 content.	 Therefore	 this	
technique	was	used	to	probe	how	structured	the	p53	peptides	are.	In	order	to	establish	if	
it	 is	 possible	 to	 use	 the	 Ru(II)(bpy)3	 complexes	 to	 stabilise	 the	 p53	 tetramerisation	
domain	peptide	structures,	 thermal	unfolding	of	 the	structured	peptides	was	performed,	
and	the	ellipticity	at	222	nm	(corresponding	to	α-helical	content)	followed	and	converted	








if	 it	may	be	possible	 to	 stabilise	 the	p53	 tetramerisation	domain	 in	 a	 low	 concentration	
buffer.	CD	spectra	of	the	two	peptides	alone	at	20	°C	showed	significant	α-helical	content	
for	 both	 (Figure	 7.8a),	 however	 there	 are	 differences	 in	 the	 spectrum,	 indicating	
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differences	in	secondary	structure	between	the	two	peptides.	Addition	of	1	equivalent	of	
Ru(II)(bpy)3	 complex	81	 to	 the	 R337H	 peptide	 shows	 a	 difference	 in	 the	 CD	 spectrum,	
indicating	 some	 change	 in	 secondary	 structure.	 Addition	 of	 4	 equivalent	 of	 Ru(II)(bpy)3	
complex	81	 to	 the	 R337H	 peptide,	 again	 showed	 differences	 in	 the	 spectrum,	 however	
much	of	this	is	 likely	to	arise	from	the	absorbance	of	the	Ru(II)(bpy)3	complex	81	which	
was	found	to	distort	the	spectra	at	these	concentrations.	
Looking	 at	 the	 thermal	 melt	 profile	 (Figure	 7.8b)	 it	 can	 clearly	 be	 seen	 that	 the	
structure	 of	 the	 R337H	 peptide	 is	 destabilised	 compared	 to	 the	 wild	 type	 peptide,	
reducing	 the	melting	 temperature	 (Tm)	 from	~52	 °C	 to	 ~29	 °C.	 On	 addition	 of	 1	 eq.	 of	









water	 look	 similar	 to	 that	 in	 5	 mM	 phosphate	 buffer	 (Figure	 7.9),	 with	 the	 wild-type	
peptide	 structure	 being	 stabilised	 by	 ~10	 °C	 in	 water	 compared	 to	 phosphate	 buffer.	
Addition	of	1	eq.	of	Ru(II)(bpy)3	complex	81	(Figure	7.9a	and	c)	looks	to	have	increased	
the	Tm	of	the		R337H	peptide	by	~10	°C	indicating	stabilisation	of	the	structure	while	the	
Tm	 of	 the	 wild-type	 peptide	 has	 been	 decrease	 by	 a	 similar	 amount,	 indicating	
destabilisation	 the	 structure.	 The	 potentially	 different	 responses	 of	 the	 Ru(II)(bpy)3	
complex	 to	 the	 two	peptides	 indicate	 that	 it	may	 be	 binding	 to	 the	 p53	 tetramer	 in	 the	
region	of	 the	mutation,	disrupting	the	 interactions	causing	tetramerisation	 in	the	case	of	
the	wild-type	peptide,	and	enhancing	those	interactions	in	the	case	of	the	R337H	mutant	




Figure	 7.9	 CD	 spectra	 in	water	 a)	 CD	 spectra	with	Ru(II)(bpy)3	 complex	81	 at	 20	 °C,	 b)	 CD	
spectra	with	Ru(II)(bpy)3	complex	35	at	20	°C,	c)	Thermal	melt	profile	with	Ru(II)(bpy)3	complex	
81,	d)	Thermal	melt	profile	with	Ru(II)(bpy)3	complex	35.	All	spectra	taken	in	water,	neutralised	by	
addition	 of	 1	mM	HCl	 or	 1	mM	NH4OH,	with	 100	 μM	 peptide	 and	 100	 μM	Ru(II)(bpy)3	 complex	
where	appropriate	
7.5.4 Conclusions	and	future	work	
Preliminary	 data,	 using	 CD	 thermal	melt	 profiles,	 has	 been	 obtained,	 indicating	 that	
the	Ru(II)(bpy)3	complexes	35	and	81	can	stabilise	structure	of	the	R337H	mutant	peptide	
of	 the	 p53	 tetramerisation	 domain.	 These	 studies	 also	 indicate	 that	 these	 Ru(II)(bpy)3	





If	 the	 data	 does	 prove	 reproducible,	 further	 experiments	 will	 need	 to	 be	 performed	 in	
order	to	show:	i)	that	it	is	indeed	tetramers	that	do	form,	ii)	an	orthogonal	experiment	to	
show	the	stabilisation,	iii)	the	stoichiometry	of	binding,	iv)	the	binding	affinity	and	v)	the	
location	 of	 the	 binding	 site.	 Potential	 platforms	 for	 determining	 these	 factors	 include	
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native	 mass	 spectrometry,	 size	 exclusion	 chromatography,	 proteolytic	 digestion,	
luminescence	 anisotropy	 and	 protein	 NMR.	 	 Further	 work	 could	 also	 be	 performed	 to	
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